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Abstract 
The 2015 series of RIO Country Reports analyse and assess the policy and the national research and innovation 
system developments in relation to national policy priorities and the EU policy agenda with special focus on ERA 
and Innovation Union. The executive summaries of these reports put forward the main challenges of the research 
and innovation systems. 
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Foreword 
The report offers an analysis of the R&I system in Israel for 2015, including relevant 
policies and funding, with particular focus on topics critical for EU policies. The report 
identifies the main challenges of the Israeli research and innovation system and assesses 
the policy response. It was prepared according to a set of guidelines for collecting and 
analysing a range of materials, including policy documents, statistics, evaluation reports, 
websites etc. The quantitative data is, whenever possible, comparable across all EU 
Member State and associated countries reports. Unless specifically referenced all data 
used in this report are based on Eurostat statistics available in February 2016. 
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Executive summary  
The report was prepared according to a set of guidelines for collecting and analysing a 
range of materials, including  policy documents, statistics, evaluation reports, websites, 
etc. The quantitative and qualitative data is, whenever possible, comparable across all 
EU Member State reports. 
The political context in Israel in 2015, which was marked by the early elections for the 
20th Knesset (Israeli parliament), held in Israel on 17th March 2015. Prime Minister 
Netanyahu was re-elected and formed a new government.  
The two main Research, Development and Innovation (RDI) bodies -- the Council for 
Higher Education (CHE) through its Planning and Budgetary Committee (VATAT in 
Hebrew), and the Israel Innovation Authority (Office of the Chief Scientist (OCS) ) in the 
Ministry of Economy– charged with making and executing research and innovation policy 
respectively – have different missions and traditionally have cooperated only on an ad 
hoc basis. However, an increasing number of programs are being launched in tandem by 
both agencies or by the OCS and the Finance Ministry. The main change in the 
innovation systems has come from a change in the OCS, which led a recent 
comprehensive strategic process that examined how to adapt to the dynamic reality. 
This process was adopted and approved by the Israeli government by government 
decision number 2092 to establish  the Israel Innovation Authority, and aims to further 
boost research and development (R&D) activities and foster technological innovation in 
the economy. The new organization is the result of closer collaboration between the 
Ministry of Finance and the Ministry of Economics, and aims to offer a more flexible 
environment towards its customers. 
The situation is complex for the high-tech industry in Israel. On the one hand, 2015 was 
a record year fund raising,  and on the other hand, this year we have seen decreasing 
indices in the manufacturing sector. Monitoring these trends, and distinguishing between 
the characteristics and needs of start-ups versus large and medium sized established 
companies is essential to innovation policy in Israel, and is seen as  the best way to 
move the country towards a more mature and integrated industry. 
In terms of public investments in R&D, Israel seems to be recovering from the effect of 
the economic crisis. GERD (Government Expenditures in Research and Development), 
measured as a percentage of the Gross Domestic Product (GDP), has been rising since 
2011 from 3.97% that year to 4.09% in 2014.  This highlights the recovery of the 
research and innovation system from the global financial conditions in 2008, which 
stems from the very high share of business in funding R&D.  However, total GERD 
figures relate only to civilian R&D, as there are no unclassified data on the total 
expenditure of the large defense-related R&D system. The government has never set out 
specific targets for R&D expenditure, and is unlikely to do so in the future. Israel is a 
highly innovative country, well above the EU average for the majority of the R&D 
indicators. Indeed, its level of innovation performance places it among the group of 
European “innovation leaders”. Only Sweden, Switzerland and Finland show higher levels 
of innovation performance. Israel is ranked second (to the United States) worldwide in 
terms of venture capital availability, thus ensuring the right conditions for highly 
innovative small companies across all sectors (European Commission, 2013). 
Israel is also a highly knowledge-intensive country. It has a strong and dynamic 
academic sector and has achieved excellence in scientific and technical education and 
research. In 2013, for example, the number of publications per thousand of the 
population was 2.04 while the average for the EU was 1.43. Moreover, the percentage of 
publications in the top 10% journals in 2010 was 14.44 compared to 12.25 for the EU 
average. The share of private-public collaborations for 2011-2013 is twice as high as the 
EU average, a remarkable difference. 
In terms of ERA (European Research Era) and Innovation union objectives the report analyses each 
of the pillars, and in general finds that the country is moving towards these objectives. For all the 
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objectives the government or the public institutions are presenting plans to improve in each of 
them. 
It is fortunate that there is an increased level of policy coordination because the Israeli 
RDI system faces three major structural challenges that require systematic solutions. 
These structural challenges are as follows: 
1. Reviving research in Israeli universities: Budgets for Israeli universities essentially 
stagnated during the first decade of the century despite a growth in the number of 
students, thus causing a decline in bibliometric scores.  
2. Over-reliance on ICT: Companies dealing with computing and communications 
technologies are one of the mainstays of the Israeli economy. However, the period 
of explosive growth for ICT is over and policymakers have been trying for a number 
of years by various means to find new engines of growth. 
3. State of Venture Capital: Returns on VC investments in Israel match returns in the 
US, where results have been disappointing. 
Israeli innovation governance does not have a tradition of formally articulating priorities 
as part of an open policy-making process. The priorities of the OCS are: new funding 
sources for the industry, help for start-ups to become mature firms, integration of 
traditional and public industries in the high tech sector, and identification of systemic 
challenges in the Israeli innovation system. 
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 WERBEH NI YRAMMUS EVITUCEXE
 השוואה בני , שניתן ככל  ,הם והאיכותיים הכמותיים וכו'. הנתונים אינטרנט  אתרי  ,הערכה  דוחות  ,סטטיסטיים
 .האירופי באיחוד החברות  דינותהמ דיווחי כל בין
 
 71 ב  כושנער - 02 ) ה לכנסת מוקדמות בחירות ידי על  אופיינה 2015בשנת  מבחינת ההקשר הפוליטי: ישראל
 מייצגת החדשה והקואליציה שינוי בעד הצביעה ישראל אוכלוסיית כי הראו הבחירות  תוצאות ).2015 במרץ
 .לכיוון הימין תנועה
 
הוועדה  באמצעות ג)"(מל גבוהה להשכלה המועצה הממונים על מחקר ופיתוח,  העיקרייםהגופים  בישראל שני
לפועל  והוצאה עוסקים בביצוע  הכלכלה והתעשייה, משרד של  הראשי המדען ולשכת לתכנון ותקצוב (ות"ת) 
 של מדיניות מחקר וחדשנות (בהתאמה). לשניהם הגדרות משימה שונות והם בדרך כלל משתפים פעולה רק
עם זאת, ישנה עלייה במספר התכניות החדשות אשר מושקות בשיתוף שני הגורמים או על ידי  במקרים נקודתיים.
  ,הראשי מכיוון המדען מגיע החדשנות במערכות העיקרי  השינוי לשכת המדען הראשי בשיתוף עם משרד האוצר.
 זה תהליך  יית החדשנות.שבתע מיתהדינא למציאות להסתגל  ניתן כיצד ובדק מקיף, אסטרטגי מהלך הוביל אשר
 הלאומית הרשות  ובמסגרתו הוקמה,  2902ממשלה מספר  בהחלטת ישראל ממשלת ידי ואושר על אומץ
 ולטפח והפיתוח המחקר פעילות את לחדשנות.מטרת הרשות, אשר תחליף את לשכת המדען הראשי, להגביר
 ומשרד האוצר משרד בין עמוק פעולה שיתוף בכלל המשק. הרשות החדשה הינה  תולדה של טכנולוגית חדשנות
 .לקוחותיה, חברות התעשייה עבור יותר גמישה סביבה  להציע רשות החדשנות מכוונת  .הכלכלה
 
 באקזיטים ובגיוסי כספים של שיא שנת הייתה 4102 אחד, בישראל. מצד טק-ההיי בתעשיית מורכב המצב
 המאפיינים בין ואבחנה אלו, מגמות  ניטור  .הייצור ענפי  דדיבמ ירידה זו ראינו בשנה שני, ומצד  טק-ההיי חברות
 החדשנות למדיניות חיוניים  הינם צעדים והבינוניות החברות הגדולות לעומת אפ-סטארט חברות של והצרכים
 ובוגרת. משולבת יותר תעשייה לקדם במדינה ביותר הטובה שזוהי דרך  נראהו בישראל
 
ההוצאה על  אחוז. הכלכלי המשבר מהשפעת מתאוששת  פ, נדמה שישראלציבוריות במו" השקעות של במונחים
 של ההתאוששות את  המדגיש  עלייה זו  4102.בשנת %90.4 ל %79.3 מ 1102 מאז  עלהמו"פ מהתוצר 
מצד המגזר העסקי  של השקעה מאוד גבוה מנתח נובעת אשר  ,העולמי המשבר פיננסי מתנאי החדשנות מערכת
  .ופיתוח מחקר למימון
על  הכוללת המשמעותית ההוצאה על מסווגים נתונים אין שכן אזרחי, ופיתוח למחקר ורק אך  תון זה מתייחסנ
 והיא פ"ההוצאה על מו לגבי מידת ספציפיות מטרות הצהירה על לא מעולם מו"פ מצד מערכת הבטחון. הממשלה
 האירופי ברוב האיחוד  וצעממ מעל הרבה  ,חדשנית מאוד מדינה היא  ישראל.בעתיד זאת לעשות צפויה גם לא
  . האירופיות  "בחדשנות המובילות " קבוצת בין אותה מציבה החדשנות ביצועי של רמה זו  ,ואכן. מדדי המו"פ
 ) בעולם השני במקום מדורגת  ישראל  .חדשנות ביצועי של יותר גבוהות רמות  ותמרא ופינלנד שוויץ  ,שוודיה רק
 סטארטאפ קטנות חברות עבור נוחים תנאים מובטחים בה ובכך, ,יכוןס הון זמינות מבחינת( הברית אחרי ארצות
 3102(.  , האירופית  הנציבות( המגזרים מכל
 
וטכני.  מדעי ובמחקר בחינוך מצוינות שמשיג ודינמי חזק אקדמי ידע. יש בה מגזר עתירת מדינה היא ישראל
 האיחוד של  בעוד שהממוצע לכל אלף נפשות בישראל. זאת 21.5הפרסומים על   עמד מספר  3102  בשנת
 44.41 היה 0102 ב המובילים בעולם  העת  כתבי עשירון העליון שלב הפרסומים אחוז34.1.  הוא האירופי
 בין אותה מציבה חדשנות בביצועי ישראל של הכללית הרמה, ,אכן  .האירופי באיחוד בממוצע 52.21 לעומת
 הוא 3102-1102 לשנים  ולה בין המגזר הפרטי לציבורישיתופי פע של  החלק  .האירופיות " החדשנות "מובילות
 .ראוי לציון  הבדל -האירופי  באיחוד מהממוצע  5פי 
 
 ובאופן  ,התווך מעמודי  אחד  כל מנתח ח"הדו  ,תחומי החדשנות האירופיים ויעדי איגוד החדשנות של במונחים
 תוכניות מציגים הציבור מוסדות או הממשלה המטרות  בכל  .הללו המטרות לכיוון נעה ישראל כי מגלה כללי
  .לשיפור
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 שלושה בפני עומדת הישראלית המו"פ שמערכת מכיוון  היא חיונית ביותר מדיניות תיאום של המוגברת הרמה
 : להלן פירוט האתגרים  .שיטתיים פתרונות הדורשים גדולים מבניים אתגרים
 
 השמרים על קפאו למעשה הישראליות  טאותלאוניברסי  התקציבים  :בישראל באוניברסיטאות המחקר  . החייאת0
 .ברמת הציטוטים  גורם לירידה וזה הסטודנטים  של כמות הצמיחה למרות המאה של הראשון בעשור
 
 
 המשק של התווך מעמודי אחד הם ותקשורת מחשוב בטכנולוגיות העוסקות : חברות TCI על יתר הסתמכות  .5
 שנים מספר מזה מנסים המדיניות , וקובעי עברה TCI  ורעב הצמיחה הגדולה של התקופה זאת  עם  .הישראלי
 .חדשים צמיחה מנועי למצוא
 
 היו התוצאות שם, ,ב "לארה בהשוואה נשאו תשואה דומה בישראל סיכון הון  השקעות  :סיכון הון מדיניות . 3
 .מאכזבות
 
  .פתוח מדיניות  ביעתק מתהליך כחלק רשמיים, עדיפויות סדרי של מסורת אין  ,הישראלית החדשנות למדיניות
 חברות בלהפוך עזרה ,לתעשייה חדשים מימון הוא: יצירת מקורות הראשי המדען לשכת של העדיפויות סדר
  ותמסורתי תעשיות שילוב ,לבוגרות
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1. Overview of the R&I system 
1.1 Introduction 
Israel is a small country with a population of 8.46 million as at the end of 2015.  The 
GDP per capita reached €28,655 in 2014, and the GDP growth reached 2.8% in 2014. In 
2014, the economic growth rate was moderate, compared to 3.3 % in 2013. This 
slowdown in growth began in the middle of 2011 and a further slowdown was recorded 
at the end of 2014. The moderation continues the trend that became apparent last year, 
because the background conditions for economic activity remained similar. This 
moderation is the result, first and foremost, of the slowdown in demand from abroad. On 
the real side, this slowdown is reflected mainly in stability in exports and investments, 
while on the nominal side, it is reflected in the low inflation environment. Excluding the 
contribution of natural gas production, growth in 2013 was moderate relative to last 
year, with a number of domestic factors contributing to this (Bank of Israel, 2013a). 
The unemployment rate in Israel is low as a result of long term processes that have 
enabled the labor market to respond relatively quickly to changes in the economic 
environment and have acted to reduce structural unemployment. The increase in the 
population’s education level has improved the matching of the qualifications of those 
looking for work with the requirements of vacant positions, while changes in the search 
process contributed to a decline in the frictional component of unemployment. As a 
result, the duration of the search has been shortened among both employers and the 
unemployed. The level of employment in export industries is more volatile than in 
domestic-market oriented industries, but the personal employment situation in export 
industries is more stable than in the rest of the business sector (Bank of Israel, 2013b). 
Moreover, a significant effort is being made to integrate the Arab and Ultra-orthodox 
populations  into the labour market (see section 5.3). 
The developments in the economy remained positive this year relative to the situation in 
other advanced economies. Per-capita growth was higher than the EU average, as in 
recent years the unemployment rate remained low and the current account surplus was 
maintained. The economy continued to grow, despite the serious shock from abroad 
which it absorbed in 2011, mainly thanks to the stability of the financial system and the 
accommodative monetary policy. 
The global environment of moderating economic activity, and particularly low monetary 
interest rates in major advanced economies, were the main background factors affecting 
economic activity and policy decisions this year. The growth rate of world trade remained 
stable and low this year, constraining the expansion of exports.  
These developments, together with the slowdown in growth in both advanced and 
emerging economies, have acted to slow growth in investments in Israel. In contrast, 
the accommodative monetary policy adopted by the central banks of advanced 
economies including Israel supported private consumption by lowering the cost of credit 
and by increasing the prices of the assets held by the public. 
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Table 1 Main R&I indicators 2012-20141  
Indicator 2012 2013 2014 EU average 
GDP per capita 30,454.38 32,415.79 32,061.56 27,300 
GDP growth rate 3.4 (%) 3.3 (%) 2.8 (%) 1.4(%) 
Government debt as % of GDP 69.6(%) 68.3(%) 67.5(%) 86.8(%) 
Unemployment rate as 
percentage of the labour force 
6.9 (%) 5.8 (%) 5.6 (%) 10.2(%) 
GERD in €m 8498.12 9217.42   
GERD as % of the GDP 4.13(%) 4.09(%) 4.11(%) 2.03(%) 
GERD (EUR per capita) 1045.67 
 
1031.25 
 
  514.5 
Employment in high- and 
medium-high-technology 
manufacturing sectors as share 
of total employment  
4.7(%) 4.56(%) 4.36(%) 5.6(%) 
Employment in knowledge-
intensive service sectors as 
share of total employment  
   39.2(%) 
Turnover from innovation as % 
of total turnover  
 28(%) n.a. n.a. 11.9(%) 
(2012) 
Value added of manufacturing as 
share of total value added 
21.0 (%) 20.0 (%) 20.0 (%) 15.53% 
Value   added of high tech 
manufacturing as share of total 
value added 
9.9 (%) (%) 4.79 (%) 4.61 (%) 3.2 (%) 
(2012) 
Research and innovation are central pillars of the economy.  In 2014 GERD reached 
4.11% of GDP compared to the EU average of 2.03% in the same year, with the 
business sector playing a major part in funding R&D. The share of employment in high-
tech and medium-high tech manufacturing sectors for 2014 was 4.36% below the 
average of Europe that year, which was 5.6%.  In contrast, in 2014 the contribution of 
value added for high-tech was 4.61 %, above the European average of 3.2%. for the 
same year. The share of turnover from innovation compared to total turnover was 28% 
for 2012, more than twice the average of the EU for that same year, which was 11.9%.  
Thus Israel is well above the EU average for the majority of the R&I indicators (European 
Commission, 2013). Indeed, as mentioned earlier, its overall level of innovation 
performance places it among the group of European “innovation leaders”. PCT patent 
applications per billion there was an average annual decrease of 1.43% over the period 
2000-2010). 
  
                                           
1 Data provided from the Israeli Central Bureau of Statistics (June 2016) 
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1.2 Structure of the national research and innovation system and 
its governance 
1.2.1 Main features of the R&I system 
Israel is a small country, and its innovation policy is not centralized but distributed 
across different ministries, while regional authorities play a marginal role. The Israeli 
innovation system is a dynamic one, with a large investment in R&D mostly from private 
funding and almost half of it coming from foreign investors.  
Israel has an active start up sector and the High Tech industry is particularly dynamic, 
especially in some sectors like ICT. All important multinationals in this sector have 
research labs in Israel: Google, IBM and Microsoft.  
The industrial dynamic sector is combined with a vibrant academic environment, which 
fosters the creation of new knowledge in a wide variety of topics. Collaboration and links 
are frequent, and successful innovations come to the market every year out of these 
collaborations, while the number of publications per capita is among the highest in the 
world. All this makes Israel a world leader in innovation, and hence this is reflected in 
any international ranking. 
1.2.2 Governance 
The main players in Israel’s national research and innovation system, which are 
responsible for policy-making and governance, are the Office of the Chief Scientist (OCS)  
in the Ministry of Economy, which is responsible for industrial R&D, and the Planning & 
Budgeting Committee (known as VATAT) of the Council for Higher Education, which 
covers academic R&D. However, since 2011, the Ministry of Finance, the ultimate source 
of funds for R&D initiated by the government and academy (GBAORD and HERD 
respectively), has become much more involved in innovation policy making. The 
heightened involvement of the Finance Ministry has helped increase the cooperation and 
coordination between all entities involved in innovation policy, including the OCS and 
VATAT.  
A lesser player both in budget and influence is the Ministry of Science, Technology and 
Space, which funds some small thematic research centres, runs 10 small regional 
research centres and is responsible for some aspects of international scientific 
cooperation. Under the Ministry's aegis is the National Council for Research and 
Development, a body that has statutory authority to devise policy and advise the 
government, but which has proved largely ineffective in recent years. 
In June 2015 the Economic Minister, Aryeh Deri, and the Finance Minister, Moshe 
Kahlon, submitted a proposal to establish the Israel Innovation Authority. The 
government approved the minister’' proposal to establish the authority, which will 
function as the executive arm of the OCS at the Israeli Ministry of Economy and Trade. 
The government's innovation policy aims at achieving broad national goals in the coming 
decade, including: encouraging the growth of industrial companies, injecting 
technological innovation into traditional fields which are not traditionally R&D dependent, 
strengthening research infrastructure as well as capital and labor, harnessing innovation 
for the improvement of the public sector and increasing the participation of sectors 
currently under-represented in the hi-tech work force. In light of the great importance of 
innovation in Israel, which in recent years has become the main engine of growth for the 
Israeli economy and a source of national pride, the government's capabilities must be 
improved, via a structural change to the OCS which is intended to bring about improved 
operational capabilities for Israeli industry. The structural change is designed to enable 
the government to continue to determine its policies in this field. 
Establishing the authority will reinforce the government's long-term goals for the hi-tech 
industry, namely, maintaining and even increasing Israel's global leadership in the face 
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of growing competition while at the same time connecting wider parts of the economy to 
this engine of growth. The authority will have the professional capabilities and maximum 
flexibility to allow it to take initiatives and efficiently promote technological innovation in 
industry at a pace that befits the market. The additional goals of the authority are 
encouraging growth, increasing productivity and promoting technological innovation in 
various fields of industry in Israel. 
Chart 1. The Israeli R&D Innovation System 
 
1.2.3 Research performers 
Outside of government, most academic research is carried out in eight research 
universities. Private Research Organizations (PRO) do not play a central role except in 
the field of agriculture. R&D in the business sector is divided between local firms (many 
of which went public on NASDAQ), subsidiaries of multinationals (mainly American 
corporations), and a large number of technological start-up companies. Many of the local 
subsidiaries of multinationals were set up after the acquisition of local start-ups. One of 
the problems of Israel's relatively large venture capital industry is that it has become far 
more difficult to float Israeli companies on NASDAQ, the preferred option in terms of 
liquidity and visibility, meaning that most of the prevalent strategy for Israeli start-ups is 
through Mergers and Acquisitions (M&A)  
In terms of specialization, there are two main fields of expertise, one which has been 
translated into a noted commercial success and another which has only partially 
delivered on expectations. There is a broad range of distinct successful ICT clusters in 
Israel with expertise ranging from semiconductors though communications to data 
security and various kinds of software. Academically, life sciences are another strong suit 
but this has been translated into a notable success only in the field of medical devices. 
Persistent government efforts to stimulate commercial success in pharmaceutical 
biotechnology have won only partial success (excluding Teva Pharmaceutical Industries – 
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an extraordinarily large international firm based in Israel). Another major area of 
expertise in knowledge intensive industries is defence exports, about which most 
information is classified. 
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2. Recent Developments in Research and Innovation Policy 
and systems 
The situation is complex for the high-tech industry in Israel. On the one hand, 2014 was 
a record year for the success of start ups and for fund raising, and on the other hand, 
this year has seen declining indices in the manufacturing sector. Monitoring these trends 
and distinguishing between the characteristics and needs of start-ups versus large and 
medium-sized companies is essential to innovation policy in Israel, and  is seen as the 
best way to move the country towards a more mature and integrated industry (OCS, 
2015)
2
.  
The year 2014 was in many ways an excellent one for Israel’s high-tech sector. About 
700 Israeli companies raised € 2.56 bn. that year. This is by far the highest annual 
amount ever invested in the Israeli high-tech industry. Even venture capital funds have 
experienced a recovery in Israeli and raised more than € 678 m.  Moreover, in 2014 
there were about a hundred exits with a total value of € 5,27 bn. The number of IPOs 
this year was the highest in the last six years and was headed by Mobileye's issuance of 
€ 768 m. This issuance, together with the sale of Viber for € 678 m., accounted for more 
than a quarter of the total value of exits during the period. 
On the other hand, when considering the long-term trends of development of the 
product and employed in the Israeli high-tech industry, it is clear that the rapid growth 
that has characterized the industry in the past has come to a stop: in the period of 
activity prior to the crisis, 2004-2007, the sector recorded an annual average growth 
rate of 13.2% of GDP; during the crisis and after, 2007-2011, the average growth rate 
dropped to 4%.  Employment reflects a worrying downward trend: in 2013, the total 
number of employees in the high-tech sector was 8.9% of all employees, compared to 
2008, for example, where the rate of high-tech employees was 10.7%. The complete 
picture is of overall sluggishness in exports and stock market data. In three years of 
high-tech exports, as measured by exports of high-tech industry, the figures have hardly 
grown. In 2014, there was even a certain decline in the exports industry (excluding R&D 
service sectors) and the share of total manufacturing exports fell from 43.7%  in 2013 to 
42.7% in 2014.  
According to the OCS, the Israeli high-tech sector is characterized by two distinct 
groups, differentiated in size and operating system. One is a mature industry of medium 
and large companies, whose activities in the high tech sectors affect the weight of 
aggregated data such as GDP, exports and employment. This industry is based on real 
activity and presents a relatively static behavior over time. On the other hand, there is 
an industry of fast operating firms – from companies to start-ups, much more agile and 
competitive, they are the ones operating in the area of venture capital and exits. This 
second group is responsible for the titles and headlines attributing to Israel the title 
“Start Up Nation", but at the same time this group is much more sensitive to waves in 
the stormy waters of the financial world. 
These two groups constitute the business environment and are interrelated. Therefore, 
the Office of the Chief Scientist, the government body responsible for addressing the 
innovation policy in Israel, offers a varied portfolio of measures to boost innovation in 
Israel. 
2.1 National R&I strategy 
One remarkable issue in the Israeli innovation system is the lack of a clear national 
strategy (Trajtenberg, 2000). The society and the business sector are very much 
oriented by themselves towards innovation. In the general understanding of Israeli 
society, compared to most European ones, technology is seen as essential to the 
                                           
2
 This section is based on the analysis conducted for the report (OCS, 2015) a  collaboration between Evyatar Kirshberg, 
from the Central Bureau of Statistics and the OCS.  
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existence of the country. There is a tendency towards innovation and entrepreneurship 
(see section 5.2). The government follows an innovation policy of supporting some 
specific needs in some areas; however, it has understood that more flexibility is needed, 
in order to  successfully help firms.  
Thus the OCS has led the recent comprehensive strategic process that examined how to 
adapt to the dynamic reality. This process was adopted and approved by the Israeli 
government by government decision number 2092 to establish the Israel Innovation 
Authority, , and aims to further boost research and development activities and foster 
technological innovation in the economy.  The new organization is the result of closer 
collaboration between the Ministry of Finance and the Ministry of Economics, and it aims 
to offer a more flexible environment towards its customers. Thus future potential 
innovators will be organized in the following domains: 
1. Early Stage. Supporting innovators since the generation of the innovation aim at 
grouping previous existing programs: Incubators, Seed program, and Nuka.  
2. Groups. Helping small and medium sized enterprise (SMEs) and big companies on 
their different projects. Basically will coordinate the previous R&D fund, a basic 
pillar in the public funding of innovation for Israel. 
3. Academic and industry relations. Based on MAGNET, will focus on building and 
sustaining a healthy network of collaboration between the universities and firms. 
Closing the gap between the new knowledge successfully carried out by 
researchers in public and academics labs and the needs of innovative firms close 
on their activities to basic research. 
4. Advanced manufacturing. Building on the traditional industries program, the plan 
is to support process innovation in traditional products by pushing firms to be at 
the peak of the innovation international frontier, and helping them to drive up the 
country’s economy and diversify its exports. 
5. Public and societal needs. This domain aims at serving societal goals. It will cover 
an extended spectrum of activities from the transmission of military technology to 
societal goals, oil substitutes and cyber security. 
All these domains will have a horizontal provider of international services, to assist 
innovators in accessing the international markets, providing them with legal support and 
informing them of international funding from which they could benefit. 
2.2 R&I policy initiatives 
The list of R&D incentives in Israel was published by the Ministry of Economy and Trade 
in 2013. The document introduce the new initiatives (OCS, 2013): 
Development of Technological Solutions for People with Special Needs 
This new provision of the OCS was designed to encourage the development of 
technological solutions for people with special needs, which it defines as “physical, 
psychological, mental or cognitive disability – temporary or permanent – resulting in a 
fundamental disruption of essential daily functions.” A special committee reviews the 
applications of non-profit and for-profit organizations with projects that do not meet 
other OCS support program criteria but do correspond to these goals.  
The ETGAR Program - Grand Challenges Israel (GCI) 
The OCS launched Grand Challenges Israel (GCI) upon joining the international initiative 
called Grand Challenges in Global Health. GCI will support the development of 
technological solutions relevant to world health and with an emphasis on R&D, which 
address humanitarian health problems in developing countries. 
Some of the health and medical challenges facing developing nations are in the areas of 
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immunization, availability of health services, sanitation, parasitic diseases, pre-natal and 
post-natal care, mental health, medical equipment, etc. In addition, there are related 
areas such as food quality, waste water treatment, advanced agriculture, desert 
irrigation, ecology, etc. In many cases, these developments which provide help to 
developing countries also have great commercial potential in the world market. 
National Program for the Return of Israeli Academics 
The program is a cooperative effort involving the Council for Higher Education, the 
Ministry of Absorption and the Ministry of Economy and Trade. The objective of the 
program is, on the one hand, to support and encourage the return of developers and 
researchers to Israel, and on the other, to assist Israeli industry to absorb quality 
personnel. The program operates primarily in the establishment of relationships between 
returning Israeli scientists and researchers and the appropriate industry and/or academic 
institution. The program is managed by a steering committee headed by the Office of 
Chief Scientist and composed of representatives of the participating institutions along 
with representatives of the Ministry of Finance. 
KIDMA programme 
As the Internet plays an increasingly significant role in every aspect of life, cyber threats 
are rapidly becoming more complex and challenging, and their global influence is 
increasing. This raises the threshold for successfully developing adequate protection 
systems. Israel’s unique advantages and leading global position in the fields of 
information security, computer security and communications security, make it a 
prominent player in the field of cyber defense. 
In order to maintain and enhance Israel’s abilities is this sector, the government issued 
Decision 3611 in mid-2011, calling for “The Advancement of National Capabilities in the 
Field of Cyber Security”. Following this Decision, a programme has been devised by the 
OCS and the Israeli National Cyber Bureau (INCB), jointly allocating €15.5 m. to 
promote the development of advanced cyber defense solutions and establish cyber 
security knowledge centres. The programme will be executed through existing OCS 
Programs (R&D fund track and the Incubator programme). 
R&D in Space Technologies  
Israel has knowledge and development capabilities in many areas in the field of space 
technology. Due to the technological complexity of the space environment, the 
development of systems and assemblies which could function in space involves high 
technological risk, as well as high development and production costs. 
In order to respond to these unique market conditions, the Ministry of Science and 
Technology and the Office of Chief Scientist (OCS) in the Ministry of Economy and Trade 
have jointly initiated a dedicated programme encouraging research and development in 
various space technologies. 
Companies eligible for this provision include those developing: products to be installed in 
satellites or in earth stations, products designated for the reception or transmission of 
data from satellites, instruments designed for testing and calibration, and equipment to 
be installed in satellites or relating to their operation, including adjustment of satellite 
versions for export. An approved project may receive government funding for up to 36 
months, subject to compliance with pre-determined milestones and in accordance with 
the approved business plan. Overall government funding per project must not exceed €4 
m. 
Alternative Fuels for Transportation 
In 2011, the Government of Israel issued a resolution to carry out a national programme 
encouraging the development of technologies to reduce global consumption of 
petroleum-based fuels and boost the development of knowledge-based industries in the 
field of alternative fuels for transportation. The government resolution entailed the 
creation of an investment encouragement programme in this field. 
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The objective of this new programme is to encourage investments in Israeli companies 
specializing in the development and implementation of technologies in the field of 
alternative fuels for transportation. The government has designated an overall budget of 
€78 m. to be utilized by 2020. 
Reduction of greenhouse emissions 
In 2010, the Government of Israel launched a national programme for the reduction of 
greenhouse gas emissions. Through this programme, the government aims to reduce 
Israel’s greenhouse gas emissions by 20%, compared to a “business as usual” scenario, 
within ten years. To do so, an investment support mechanism has been established to 
encourage the installation of cleaner and less polluting systems, by offering a subsidy of 
up to 20% of the cost of the project, up to a ceiling of € 1.3 m.  In 2013 this project was 
effectively closed down. 
In September 2015, Israel determined its INDC (Intended Nationally Determined 
Contributions) for the reduction of per capita emissions. It committed itself to reducing 
the per capita emission by 26%, compared to the levels in 2005, and announced a new 
National GHG Reduction Plan, which set the following targets: 
 17% decrease in electricity consumption (compared with business as usual 
based on 2015 trends) 
 Increase in the use of renewable energy to 17% for total energy production. 
Currently 2% of electricity is produced from renewables 
 20% reduction in the use of private vehicles, compared to business as usual, 
through improvement of public transportation and a transition from diesel to 
compressed natural gas for heavy vehicles 
The programme has been allocated € 105.03 m. In addition, € 63.22 m. will be provided 
in financial support from 2016-2019 to Israeli companies to invest in energy efficiency. 
Designated Biotechnological Incubators 
Biotechnological incubators support the formation of biotechnology startup companies in 
order to lead them toward clinical trials and Round A investments. For a period of three 
years, the program provides companies whose projects were approved by the Incubators 
Committee with full financial support (€ 1.5 m.) of which 85% is granted by the 
government and 15% is invested by the incubator), payable only upon generation of 
sales, in the form of 3% of the revenues annually. 
Technology-Based Industrial Incubators 
Technology-based industrial incubators support the ongoing operations of startup 
companies in order to lead them toward commercialization and market penetration. For 
a period of two to three years, the program provides companies whose projects were 
approved by the Incubators Committee with full financial support (€ 770,000) of which 
50% is granted by the government and 50 percent is invested by the incubator), payable 
only upon generation of sales, in the form of 3% of the revenues annually. 
Assistance for New Start-Up Companies 
Seed companies typically find it difficult to raise the funds required in order to complete 
their initial R&D and become commercial. The financial crisis of recent years has created 
a leaner and more conservative global VC community. It has also increased the shortage 
of funding at this crucial stage of a company’s life, known as “the valley of death”. The 
State of Israel, through the OCS in the Ministry of Economy and Trade, has created a 
new program to address this issue. 
This new program offers an approved seed company a funding commitment of 50% of 
the R&D expenses from the OCS, up to € 950,000 for up to two years. It then allows six 
months for the company to seek investors, thus giving the investor the assurance that 
(a) the rest of the funds necessary for the completion of the product development have 
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been obtained, and (b) the company in which the investor is considering investing is 
highly innovative. 
Academitech – Student Initiative Competition 
Academitech is a competition at the student level, established by the OCS for the 
development of an innovative product. The competitors are groups of students from 
institutions recognized by the Council for Higher Education who will present a Proof of 
Concept for a commercial product. Any field of study is eligible for the competition. The 
awards for the winners will be € 21,073 for the first prize, € 15,804 for the second and € 
10,536 for the third, to be used toward the development and commercialization of the 
initiative. 
The primary objective of the competition is to expose students to the world of 
entrepreneurship by providing support and direction to further their concept. The 
judgment criteria in this competition will be based on the idea of the product, the need 
that it addresses, the targeted market etc. The product should be innovative and unique 
and utilize either new or novel technology. The competitors will not be required to 
actually produce the final product but rather the idea should be relatively easy to 
implement. 
Young Entrepreneurs 
In order to keep Israel at the forefront of high-tech activity in the future, the OCS has 
embarked upon a program of encouragement and training of young entrepreneurs by 
involving them in various phases of development projects. 
The program, in conjunction with Technological Incubators, provides high school 
students with the basic knowledge and foundation needed for their future as developers 
and entrepreneurs. The students enjoy all the services provided by the incubators from 
leading consultants and project leaders in various fields. 
Thus the program provides high school students with knowledge and experience of the 
evolutionary process of a new technological development. 
Israeli National Renewable Energy Center 
The Government of Israel, in an effort to enhance Israel’s capabilities in the field of 
Renewable Energy Technologies, has declared the creation of a technological center for 
renewable energy solutions in the South of Israel. The center operates a Venture Track, 
a Test and Validation Track and a Research Track. Through these tracks it supports 
technological entrepreneurship from the initial R&D stages to the production and 
marketing ones, as well as encouraging cooperation between academia and industry 
towards the development of innovative renewable energy solutions. The center also 
serves as a focal point for applied research in these fields. The State of Israel has 
allocated a budget for this program of € 10.5 m. over a five-year period.  The Center 
was launched in 2012 by the investment firm Capital Nature, which had been selected to 
operate it after winning a government competitive process. 
TELEM Forum 
TELEM is a voluntary partnership between the OCS and the Ministry of Economy and 
Trade, the Ministry of Science & Technology, the Planning and Budgeting Committee of 
the Council for Higher Education., the Ministry of Defense and the Ministry of Finance. 
TELEM encompasses several programs aimed at establishing a national infrastructure for 
R&D in areas that are of common interest to the forum’s members. The financing of the 
projects is carried out with TELEM members’ own resources. 
Support for Israeli Research Institutions 
This program assists research institutions with clear links to industry in strengthening 
their technology infrastructure and developing relevant technologies and products. For a 
research institute to qualify for support, it must be an independent legal entity, employ a 
team of researchers with proven scientific and technological abilities, have equipment for 
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conducting and testing industrial R&D and gain at least 30% of its revenue by providing 
services to industry. Grants given may be up to 90% of the approved budget for up to 
two years. At least 10% of the budget of an approved project must be provided by an 
industrial company. 
Long-Term R&D Support for Large Companies with Substantial R&D Investment 
This program is designed to encourage long-term R&D – which is typically higher risk 
and more expensive – in companies with more than 200 R&D employees or an annual 
R&D budget of at least € 15.8 mand yearly revenues exceeding  € 75.4 m. Grants may 
be up to 50% of the approved R&D budget. No royalty payments are mandated. 
MAGNET  
MAGNET (the acronym in Hebrew for Generic Pre-Competitive R&D) encourages 
collaboration among industrial companies, and between the companies and researchers 
from academic institutions, through several instruments that deal with innovative 
technologies. These instruments seek to develop Israel’s industrial infrastructure by 
supporting the R&D activities and sharing technological knowledge among the 
participants. MAGNET works through the formation of consortia composed of industrial 
companies and academic institutions, in order to jointly develop generic, pre-competitive 
technologies. The duration of a MAGNET consortium is 3-5 years. Grants are up to 66% 
of the approved budget for industry and up to 80% for academic institutions. 
NOFAR  
NOFAR is designed to bridge the gap between know-how within academia and the needs 
of industry. It does so by encouraging support for applied academic research activity by 
an industrial company. The academic research group gains a better understanding of the 
market’s needs and tendencies, while the company taps into ground-breaking 
discoveries in its field of activity. The program supports applied academic research in the 
following technological areas: biotechnology, nanotechnology, medical devices and 
storage of water and energy. 
The project’s budget is up to € 97,000 for a period of 15 months. Grants cover up to 
90% of the approved budget, to be complemented by the industrial company associated 
with the project. No royalty payments are mandated. International technology 
companies are invited to connect with an Israeli academic research institute and take 
part in the programme. 
Nanotechnology 
From 2005 to 2012, six nanotechnology academic research centres were founded and 
put into operation in Israel. They were funded by collaborative private and public 
resources and collectively received a total budget of € 75,500 m. 
A follow-up programme was implemented in 2012, for the next four years, the main goal 
of which is to establish a strong nanotechnology industry by transferring technologies 
from academia to industry and by creating a pool of skilled PhD and MSc graduates in 
Nano-science. 
Isragrid 
The goal of this programme is to enable efficient e-Science research in various fields by 
providing production e-Infrastructure that takes advantage of grid and cloud computing 
technologies. Isragrid offers the industry access to compute/data resources via EGI 
(European Grid Infrastructure), as well as user support and training. 
2.2.1 Evaluations, consultations and foresight exercises 
The work plan of the Office of Chief Scientist for 2015 includes innovation areas, 
organizational changes, expanding database tools, continuous assistance and listening to 
customer needs, and identifying trends and challenges in Israel. An analysis of the 
challenges already met by the Office has concluded that the main one now is to 
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strengthen Israel's lead cutting-edge success in the high tech industry. This major 
challenge will detail a number of evaluations, identifying the main points to be tackled in 
the coming years (OCS, 2015, Chapter 2), as follows: 
1. The need to create new funding sources for industry: Although 2014 was a record 
year in raising funds for high-tech, a long-term review of the trend shows that the 
sources of funding suffer fragility: the model venture capital has experienced in recent 
years shook deriving from economic crisis. Moreover, the status of the local stock 
market has been eroded and many companies are choosing to raise money on foreign 
stock exchanges. In light of these changes, industry is required to obtain alternative 
sources of financing such as financial institutions or the general public through the mass 
finance platforms. 
2.  The challenge of helping start ups to become large companies: Israel is blessed 
with an abundance of start-ups, but many of them are quickly sold to big companies and 
they do not grow to produce in Israel. Large companies employ a large differentiated 
number of workers. The challenge of growing includes not only the generation of 
technology; but also the identification of market trends, an understanding of foreign 
cultures and familiarity with different business models. 
3. The need to integrate technologies in traditional and public sectors: Israel's traditional 
industries are characterized by a low innovation intensity and productivity. Increased 
awareness of the need to renew, and expanding access to advanced technologies and 
R&D are the foundation for improving productivity in these areas. 
4. Identification of systemic challenges in innovation: The complex system of innovation 
that operates in the high-tech industry can point to necessities that have implications for 
the industry but are difficult to point out. Nevertheless, the role of the Chief Scientist is 
to serve as an active player in identifying and voting on these challenges and to act as a 
catalyst for the development of a solution to them. For example, the worrying trends in 
terms of the need for highly qualified personnel constitute a significant barrier to the 
development of high-tech industry. Hence the OCS's commitment to point out the 
challenge, to become a partner in dealing with systemic activity and develop appropriate 
tools. 
2.3 National and Regional Research and Innovation Strategies in 
Smart Specialization 
The decision of the Israeli Cabinet to increase the Ministry of Science and Technology’s 
budget for its regional research and development centres can be interpreted as a 
measure for Smart Specialization. The budget was increased by €1.8 million, a tripling of 
the budget, for the eight centres located in peripheral areas
3
 in the north to the Negev 
desert in the south. The Ministry is a partner in the establishment of these centres, in 
guiding its scientific activity and contributing substantially in their funding. 
The Regional Research and Development Centers were established in the peripheral 
areas to draw young, leading scientists into these areas, to contribute to the 
improvement of local society and to raise the level of local education. Furthermore, the 
Centers’ research focuses on local challenges, conditions and resources in order to 
provide solutions for local needs. They thus present a ground-breaking model that is 
unique to the State of Israel. 
An example of regional smart specialization is the area of Beersheva in the south of 
Israel, where the focus is on cybersecurity. The CyberSpark Industry Initiative has 
become the central coordinating body for joint cyber industry activities with government 
agencies, the Israeli Defense Forces (IDF), the public and academia. The Initiative is 
formulating a multi-year business plan, leveraging the region’s significant strengths and 
maximizing its potential in the field of cyber security technology. It is marketing the 
                                           
3
 The smart specialization programme of Galilee was analyzed by the Jerusalem Institute for Jewish Studies in  2012. 
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region and the city of Beer-Sheva as a global cyber security center, encouraging joint 
academia-industry partnerships and supporting the articulation of plans to recruit and 
develop human resources in the field, as well as incentive plans to attract other 
companies, whether international or Israeli, to establish projects or base themselves in 
the region. 
Two new programs have already been launched: the Cyber Executive Academy 
CyberSpark, Israel – an International School of Cyber Training for Senior Executives and 
Decision Makers – and a CyberSpark Affiliates program. Accessing the cumulative 
knowledge of the CyberSpark partners, these professional programs offer participating 
companies and organizations access to the people and ideas that are shaping cyber 
security strategies and technologies today. Unfortunately, there is no monitoring 
strategy in place to track the evolution of these programs, as their evaluation is done 
internally by the Ministry responsible for them, and it has never been made public. 
.
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2.4 Main policy changes in the last five years 
The summary table below shows the timeline of the recent policy changes: 
Main changes in 2011 
… VATAT program. (Implemented in 2011 signed in 2010). A six-year program to improve and 
renew academic research. 
…I  Core Programmes for centres of research excellence. (First phase) 
 
Main changes in 2012 
… Kamin. 
… Tzatam. 
… Maimaid. 
…II  Core Programmes for centres of research excellence. (Second phase) 
Main changes in 2013 
…Kidma. 
…R&D in space technologies. 
…Alternative fuels for transportation. 
Main Changes in 2014 
…Solutions for people with special needs. 
…Israeli National Renewable Energy Center. 
…Program of assistance for seed companies. 
Main changes in 2015 
… Creation of the Israel Innovation Authority as a more flexible government institution.  
…Telem forum. 
… Cyberpark in Beersheva. 
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3. Public and private funding of R&I and expenditure 
3.1 Introduction 
Table 2 Basic indicators for R&D investments 
Indicator 2011 2012 2013 2014 EU average (last 
available year) 
GERD (as % of GDP) 4.01 % 4.13 % 4.09 % 4.11 % 2.03 % (2014) 
GERD (Euro per capita) 1,025 1,124 1,146 1,119 536 (2013) 
GBAORD (€m) 1,130 1,184 1,238 1,457  
R&D funded by BES (% of 
GDP) 
1.55 % 1.42 %   1.12 % (2013) 
R&D funded by PNP (% of 
GDP) 
 0.45 % 0.48 %   0.03 % (2012) 
R&D funded by ONS4 (% of 
GDP) 
0.15 % 0.14 %   0.05 % (2012)5 
R&D funded from abroad (% of 
GDP) 
1.88 % 1.95 %   0.19% (2012) 
R&D performed by HEIs (% of 
GERD) 
12.92 
% 
12.80% 12.55% 12.31% 23.38 % (2013) 
R&D performed by government 
sector (% of GERD) 
2.09 % 1.99 % 1.89 % 1.89 % 12.43% (2013) 
R&D performed by business 
sector (% of GERD) 
83.79 
% 
84.11 
% 
84.46 % 84.71 
% 
63.68 % (2013) 
In terms of public investments in R&D, Israel seems to be recovering from the effect of 
the crisis as can be seen in the table above. GERD, measured as a percentage of GDP, 
rose steadily from 4.01% in 2011 to 4.11% in 2014. This highlights the recovery of the 
research and innovation system to global financial conditions, and stems from the very 
high share of business in funding R&D.  Total GERD figures relate only to civilian R&D, as 
there are no unclassified data on the total expenditure of the large defense related R&D 
system. The government has never set out specific targets for R&D expenditure, and is 
unlikely to do so in the future. 
The contribution of the business sector to the funding of R&D continues to rise, with its 
share of GERD reaching 84.71% in 2014. These levels, although normal for Israel, are 
surprisingly high, especially when compared with the EU average for 2013, where BERD 
contributed  63.68% of the GERD. 
According to last available data6 , in 2014 national expenditure on civilian R&D was 
4.11%, following a constantly increasing trend from the level of 4.01% in 2011 (See 
Table 2).  Following these estimations by the CBS, in 2014 the national expenditure on 
civilian R&D, at constant prices, increased by 3.4%, following an increase of 0.4% in 
2013 and of 4.1% in 2012. 
The expenditure on civilian R&D (at current prices) in the business sector amounted to € 
7.66 bn. in 2014, comprising 84.71% of total national expenditure on R&D. The rest was 
expenditure on R&D carried out at universities (12.31%), in the general government 
sector (1.89%) and in private non-profit institutions (1.09 %). 
                                           
4
 ONS . Other National Sources. The author was not able to obtain information on  HES. These data come from MSTI Table 
Eurostat.  The average for the EU isalso  taken from the MSTI database. 
 
6
 Data provided through personal contact with the Israeli Central Bureau of Statistics (June 2016).  
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Taking a deeper look at the business sector, the development, at constant prices, 
reflects a 3.6% increase in expenditure on R&D in the business sector in 2014, following 
an increase of 0.1% in 2013, and of 4.5% in 2012. This sector includes computer 
programming, consultancy and related activities (software); scientific research and 
development (R&D); and manufacturing industries. In 2014, the expenditure on R&D in 
computer programming, consultancy and related activities (software) increased by 
5.5%, at constant prices, following an increase of 4.4% in 2013. The expenditure on 
scientific research and development (R&D), including start-up companies, international 
R&D centres, technological incubators and research institutes, increased by 5.1%, after 
a decrease of 2.2% in 2013. 
 
Figure 1. Evolution of R&D 2014, by Operating Sector (CBS data). 
 
3.2 Smart fiscal consolidation 
Israel is an example of a country that has followed the principle of smart fiscal 
consolidation. The principle of smart fiscal consolidation, albeit it is not a concept used in 
public discussion. Hence, government debt has fallen from 69.9 % of the GDP in 2012 to 
67.5% in 2014. Moreover, it seems to follow a stable decreasing trend. Meanwhile the 
proportion of public expenditure in R&D rose in those same years from 3.97% to 4.21%. 
The public debt has been reduced, yet it has never been at the expense of public 
investment in innovation. The country is well aware of the role of technology in society, 
and the public spending on science and technology is normally reviewed for increase 
before the approval of the next public budget 
3.3 Funding flows 
3.3.1 Research funders 
The main funders of public investments in Israel are the Ministry of Economy and the 
Ministry of Finance, while the Ministry of Education deals with the increase in the quality 
of researchers in Israel. These three main bodies represent the majority of public 
investment in the country (see section 1.2.3). The Ministry of Science and Technology, 
with a much smaller budget, as well as the Ministry of Finance, also carry out a number 
of innovation projects.  In general, all the ministries deal with innovative ideas and 
proposals that are close to their corresponding political area. 
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Other important actors in the Israeli innovation system are: 
 The Israel Science Foundation (ISF), which is Israel's predominant source of 
competitive grants for funding basic research. Its roughly € 105 m. million annual 
budget funds more than 1,500 grants a year, providing 2/3 of all such funds. Every 
year, more than 15,000 expert reviewers, some from Israel but most from abroad, 
are involved in peer-reviewing the scientific merit of the proposals submitted. The 
ISF awards grants to Israeli researchers at Israeli universities, other institutions of 
higher education, research and medical centers. Most funds (96%) are provided by 
the Government of Israel via the Planning and Budgeting Committee (PBC) of the 
Israel CHE.  
 Bi National and International Funds. (see sections 4.2 and 4.3) 
 The OCS deals with all the new funds introduced in recent years (see section 2.2) 
 I-CORE - the Israeli Centers for Research Excellence - is an initiative designed by the 
Planning and Budgeting Committee and the Government of Israel, which is gradually 
establishing leading research centers that specialize in a range of disciplines. The 
Centers of Excellence and the program’s vision are aimed at fundamentally 
strengthening the long term positioning of Israel's academic research and its stature 
among leading researchers in Israel and abroad. 
 The University Research Authorities:  Bar-Ilan University, Ben Gurion University, the 
Hebrew University, the Open University, the Technion, Haifa University and the 
Weizmann Institute. 
 Foundations: each university is associated with a principal foundation that supports 
innovation. 
 The University Vice-President or Deans for R&D.  
3.3.2 Funding sources and funding flows 
Israel has been steadily increasing its participation in the different Framework 
Programmes (FP). It has become especially important, since during the last negotiations 
dealing with the participation of Israel in the H2020, the tension between Israel and the 
European Commission raised to the media.  Scientists and politicians in Israel 
highlighted the need for these collaborations to continue (see Garcia-Torres, 2013).  
Table 3 shows that the participation of Israel in FP6 accounted for  17.25 % of all the 
contributions to associated member states.  In addition, if we compare with the total 
contribution given to EU members it represents 1.1 % of the total grant given to the 
EU28. In the case of FP7, 21.21 % of the total provision was given to associated 
member states which represents a 2.11% of the total provision given to EU28 For 
H2020, given its early stage it may be too soon to derive conclusions but based on the 
number of projects already signed, Israel has reached 31.75 %. The evolution shows the 
clear involvement of Israel in the European research programs as well as increasing 
participation in them.  However, the table should be compared with caution, since 
different Framework programs have run for more than a year, and this makes it difficult 
to compare these resources to national ones, which are mostly given yearly. 
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Table 3  Participation of Israel in FP and H2020 
 
No. of 
projects 
 % No. 
of 
project
s 
No. of 
participants 
No. of 
coordinators 
EU 
contribution € 
% of total 
AMS EU 
contribution 
% of total 
EU28 EU 
contribution 
 
FP6   
Israel 592 
 
772 117 174,838,876 17.25% 1.11% 
Total Grant to 
Associated MS 3.602 16.44% 5.080 570 1,013,504,931 100% 6.44% 
Total Grand to 
EU28 36796 1.61% 67696 9328 15,749,796,104 
 
100% 
 
FP7   
Israel 1.641 
 
1.998 796 862,647,412 21.21% 2.11% 
Total Grant to 
Associated MS 8.471 19.37% 11.100 2.656 4,067,287,591 100% 9.94% 
Total Grand to 
EU28 72.440 2.27% 120.697 23.204 40,917,932,471 
 
100% 
 
H2020   
Israel 390 
 
533 242 308,247,000 31.75% 
 Total Grant to 
Associated MS 1.101 21.89% 1.441 295 n.a. 100% 
 Total Grant to 
EU28 13.219 1.82% 21.851 4.970 n.a. 
 
100,00% 
 
 
3.4 Public funding for public R&I 
3.4.1 Project vs. institutional allocation of public funding 
According to the data provided by the CBS in Israel
7
, competitive funding was 37.8 % of 
the total institutional public funding in the 2011 budget. This represents a mild increase 
after 2010, though still without reaching the 2009 level of 39%. A large proportion of the 
competitive funding is awarded by the Israel Science Foundation (ISF), the main source 
of competitive grant funding for basic research in Israel. With an annual budget in 2014 
of roughly €105 m., ISF funds more than 1,500 grants a year, providing 2/3 of all such 
funding in the country. Its funds are mostly (96%) provided by the Government of Israel 
via the Planning and Budgeting Committee (VATAT) of the Israel Council for Higher 
Education (CHE).  
Funding for universities is expected to increase annually by 30% over the course of the 
VATAT plan, while allocations to the ISF will nearly double. In 2012, the total budget for 
Higher Education was € 8.2 bn. However, the proportions between block and competitive 
funding are unlikely to change to any significant degree because the share of total 
university funding earmarked for research, as opposed to teaching, is increasing from 
about 40% to 50%. 
 
  
                                           
7
 Data provided through personal contact with the Israeli Central Bureau of Statistics (October 2015 ) 
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3.4.2 Institutional funding  
Government ministries’ expenditure on civilian R&D amounted to € 1.45 b. in 2014. The 
expenditure includes conducting research, commissioning research from other 
institutions and transfers for financing of R&D in other sectors, including the General 
University Fund. The Ministry of Economy and Trade, which constituted 62% of the 
overall expenditure of Government ministries on R&D, financed most of the government 
ministries’ R&D (excluding GUF). The Ministry of Economy and Trade’s R&D expenditure 
increased, at current prices, by 5.6% in 2014. 
The breakdown of expenditure on civilian R&D for government ministries, by objectives, 
shows that in 2014 the share of grants for the advancement of research, which mainly 
includes the financing of the General University Fund and is oriented towards the 
universities, amounted to 56%. Expenditure for the advancement of industrial 
technology amounted to 30%. The main expenditure in this field was for grants awarded 
by the Ministry of Economy and Trade to industrial companies; 6% of R&D expenditure, 
in 2014, was allocated to R&D in agriculture; 3% for research in social services 
(education, labor, social welfare, immigrant absorption, etc.), and 3% was allocated to 
R&D in infrastructure (including research on transportation and on urban and rural 
planning). 
To fund and coordinate research initiatives, there is a voluntary forum called TELEM, 
composed of the chief scientists of the Ministry of Economy and Trade, the president of 
the Israel Academy, and representatives of the Council for Higher Education, the 
Treasury, and others. There is no institutional evaluation of the programs. 
The Israel Science Foundation (ISF) is the main body supporting breakthrough basic 
science in Israel, based on scientific excellence within the different fields of knowledge, 
in a wide variety of funding opportunities. The ISF focuses on the following main fields: 
exact sciences and technology, life sciences and medicine, humanities, social science and 
special programs.  
The selection of the successful projects is conducted in the following way: in order to 
obtain a minimum of three to four reviews for each research proposal, the ISF contacts 
approximately ten potential reviewers, national or international, for each proposal. 
Despite the increase in the number of research proposals submitted each year, the ISF 
succeeds in keeping to an average of four reviews per proposal.  A set of different 
professional committees is formed every year depending on the topics submitted, and it 
is in charge of distributing the budget. The selection criteria are based on the 
assessment by the professional committees. The success rate is 42.5% of the proposals 
submitted.  Since 2002, 2.1% of the ISF total budget has been devoted to individual 
grants in the form of post-doctoral grants. 
3.4.3 Project funding 
3.4.4 Other allocation mechanisms 
Although it is neither a project nor an institutional allocation of funding, it is worth 
highlighting the cluster called “Silicon Wadi”. It is an area with a high concentration of 
high-tech industries on the coastal plain in Israel, similar to Silicon Valley. The area 
covers much of the country, although especially high concentrations of hi-tech industry 
can be found in the area around Tel Aviv including small clusters around the cities of 
Renana, Petah Tikva, Herzliya, Netanya, the academic city of Rehovot and its neighbour 
Rishon Le Zion. In addition, hi-tech clusters can be found in Haifa and Caesarea. More 
recently such clusters have been established in Jerusalem, and in towns such as 
Yokneam Illit.  
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3.5 Public funding for private R&I  
3.5.1 Direct funding for private R&I 
The main public programs for public policy are organized around the idea that really 
successful innovations use the VC markets to obtain the support they need. A large 
proportion of R&D is performed in the business sector with a huge proportion of the 
investment coming from foreign investors. The public policy for innovation represents 
only a small slice of the big innovation pie, but the public sector is well aware that its 
role is only marginal and covers the needs that private markets are not able to supply.  
In general, the OCS in collaboration with the Ministry of Finance has created  the Israel 
Innovation Authority (see section 2.1) with the clear idea that more flexibility was 
needed to meet the special needs of innovators. In general, the OCS is aware of the 
need for financial support not only to SMEs but also to new ideas in its earliest stages, 
which is why it has a pre-seed program. The idea is to cover all the different needs of 
innovators, from the initial stage until the product is brought to the market.  A special 
domain of  the Isarel Innovation Authority  is devoted to societal needs, to complement 
the ongoing research carried out in Israel (see section 3.4.3.6 ). 
Collaboration between the public and private sector is stimulated basically by MAGNET, 
the consortia created to close the gap between academy and high tech industry. Some 
more specific programs included under this umbrella are NOFAR, Meimed, TELEM and 
Tzatam. (For a better description, see Section 2.1).     
In general, very little research has been done on benchmarking innovation in Israel, 
apart from the international comparisons made by the international organizations OECD, 
IMF and European Commission. Programmes are evaluated internally by the Ministries, 
but such evaluations are not made public. 
Public procurement in Israel relates mostly to the R&D Fund, which is the main 
instrument of the R&D Law. It gives grants to “Approved R&D Programs”, which are 
programs lasting one or more years, and resulting in the development of a new product 
or in a significant improvement to an existing one. It may also lead to a new industrial 
process or, again, to a significant improvement in an existing one.  
A special track is dedicated to traditional industries (those characterized by relatively low 
investment in R&D). This track offers separate evaluation and discussion for projects. 
Another special track, which has been operating since 2010, supports large companies in 
establishing their R&D centres on Israel’s periphery. It aims to bridge the gap between 
Israel’s centre and its periphery, by convincing large companies to locate their R&D 
centres in areas with less economic growth. This creates a mechanism of increased 
quality employment and economic activity within the target geographical areas. 
There is no strategic framework of innovation procurement in Israel. There is an 
intention to offer public services online, but it is in the discussion phase, and there are 
no financial incentives to undertake innovation procurement. 
3.5.2 Indirect financial support for private R&I 
Income tax ordinance allows recognition of a company’s R&D expenses incurred for 
promotion and development as suitable for tax deduction. This is on condition that these 
expenses are due to scientific research in the fields of industry, agriculture, 
transportation and energy and are approved by the OCS. These expenses will be 
deductible regularly during the tax year in which they were paid. If the scientific 
research expenditure is not approved by the OCS, the expenses will be deductible in 
three equal annual instalments starting in the fiscal year in which they were paid.  
Israel’s corporate tax rate is 26.5% of business income. The OCS of the Ministry of 
Economy  implements the government's policy encouraging and supporting industrial 
research and development. They are responsible for promoting industrial R&D that is 
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likely to lead to new export products. The following incentives are available only if 
approved by the OSC after applying the following criteria: the proven technological skill 
of the applicant, a plan to implement the project in Israel (unless exempted by the 
research committee of the OCS), and the high standards of technological innovation are 
met. 
Tax benefits are given to two kinds of companies: those located in priority area A 
(central area), which are eligible for a lower tax rate of 7% in 2013-2014 and 6% for 
years after 2014. Companies that are not located in priority area A are eligible for a 
lower tax rate of 12.5% in 2013-2014, and 12% from 2015 onwards.  If the company 
pays dividends during a tax year in which the complete exemption is effective, the 
dividends are taxed at 15% and any exempted taxes become payable immediately. 
Companies located in Priority Area A may also qualify for grants for investing in their 
manufacturing facilities. Grants are distributed by the Investment Center at the rate of 
20% out of the total investment. There are other special benefits for selected fields, like 
traditional industries and large corporations generating employment outside the 
industrial periphery.   
3.6 Assessment 
As mentioned in the previous section, the role of public R&D funding in Israel plays a 
minor role. However, there is a good mixture between project and institutional support 
measurements. Competitive funding is always implemented via peer review with 
renowned international professors on most of the committees.  
The Israeli innovation policy aims at covering the failures that the free market is not able 
to cover. There is almost no indirect support that does follow a strategic project for 
innovation and most innovation policy is implemented through direct funds. Innovation 
policy is divided across too many ministries and a higher level of unification could benefit 
the country. Moreover, there is not a clear political position towards a direction among 
many possible different technological paths that the country could follow. The direction 
of the technology in Israel is decided by industry, and mostly based on profitability 
decisions, but so far the country has been extremely successful in most of its 
technological trajectories. The mixture between funding allocation has changed very little 
in the last years. However, this indicates that the country has recovered from the shocks 
of the international crisis at least in relation to investments in R&D.  
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4. Quality of science base and priorities of the European 
Research Area  
4.1 Quality of the science base 
Indicator Year EU average 
Number of publications per 
thousand of population 2013 
2.04 (FULL) 
1.44 (FRAC) 
1.43 (FULL) 
1.22 (FRAC) 
Share of international co-
publications 2013 
 
46.6% 36.4 % 
Number of international 
publications per thousand of 
population 2013 
7573 262593 
Percentage of publications in 
the top 10% most cited 
publications 2010 
14.44 (FULL) 
11.6 (FRAC) 
12.25 (FULL) 
11.41 (FRAC) 
Share of public-private co-
publications 2011-2013 
 
3.3% (Scival) 
N/A 
1.8% 
Israel is a highly knowledge-intensive country. It has a strong and dynamic academic 
sector and has achieved excellence in scientific and technical education and research. As 
commented in previous sections, Israel is well above the EU average for the majority of 
the R&I indicators.  A similar comparison is made for indicators of the quality of the 
science: in 2013 the number of publications per thousand of the population was 2.04 
while the average for the EU was 1.43. It is well ahead in the international index for co-
publications, reaching 46.6% in 2013 compared to the average of 36.4% for the same 
year.  The percentage of publications in the top 10% of journals in 2010 was 14.44 
compared to 12.25 for the EU average. Indeed, Israel’s overall level of innovation 
performance places it among the group of European “innovation leaders”. The share of 
private public collaborations for 2011-2013 was twice as high as the EU average, a 
remarkable difference. 
The increase in research via open national competition in Israel is channeled through two 
main sources, the competitive R&D fund and the VATAT. The competitive R&D fund is 
the main instrument of the R&D law. It gives grants to approved R&D programs that last 
one or more years, resulting in a new product or process. It is therefore a grant given to 
firms for applied research, and the development may lead to a new industrial process or 
to a significant improvement in the R&D.  The Planning and Budgeting Committee 
(VATAT) is the main instrument for financing basic research, i.e. research done by 
universities. In Israel they remain autonomous: once they are given their budget they 
are at liberty to decide how to use this budget within the university – for teaching or for 
research. The financing is allocated by VATAT, following a model by which the 
universities´ achievements both in teaching and research are measured. 
Israel has been associated with EU research and innovation programs since 1996. The 
collaboration between Israel and Europe can be explained through three main areas: 
H2020, the program EUREKA, and bilateral collaboration with European countries.  
During the last FP7 programme (2007-13), Israeli public and private institutions 
contributed their scientific expertise to over 1,500 projects. Reflecting the strength of 
Israeli research, Israeli participants achieved a high success rate, particularly in 
obtaining European Research Council (ERC) and Marie-Skodowska Curie grants. In the 
thematic programs, Israel participated most actively in the areas of Information and 
Communication Technologies (ICT), Health, demographic change and wellbeing and 
Nanotechnologies, Advanced materials and Advanced Manufacturing and Processing. 
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Overall, 8,984 Israeli entities were included in 6,109 submitted program proposals, 
resulting in 2,115 Israeli entities participating in 1,200 retained projects, with a total 
cost of €10.1 billion. The total grant value for Israeli entities amounted to €875.6 million. 
On its side, Israel contributed over € 530 million to the programme. 
On June 8, 2014, Israel signed an agreement to join Horizon 2020, the eighth European 
Framework Program for R&D. Retroactively joining the program officially as of January 1, 
2014, Israel has access to the €70 billion in total program funding of which Israel will 
contribute about € 1 bn. during 2014-2020. The central objective of Horizon 2020 is to 
maintain the European Community’s status as a world leader in science and in industrial 
innovation through the availability of capital, along with support for SMEs (see Table 3 in 
subsection 3.3.2). Horizon 2020 provides funding in the following areas: health, food, 
agriculture, biotechnology, bioeconomy, information and communication technologies, 
big data, nano-sciences and nanotechnologies, energy, environment and climate change, 
transport and aeronautics, socio-economic sciences and the humanities, space and 
security. Horizon 2020 allows mobility of research, promotes pioneering research and 
enables Israeli entities to cooperate in technological development with European 
industries, research institutions and universities, and showcase Israeli technological 
abilities. Through Horizon 2020, small and medium-sized enterprises that are EU-based 
or established in a country associated with Horizon 2020 can obtain EU funding and 
support for innovative projects that will help the enterprises to grow and expand their 
activities into countries in Europe and elsewhere. From the begining of H2020 (2014), 
3,631 Israeli participants were included in 2,616 submitted proposals resulting in 391 
retained projects, with a total cost of 1.952,5M€ ..  
Israel is an active participant in the EUREKA Network, Europe’s leading platform for R&D 
entrepreneurs and industries. EUREKA is an inter-governmental public network of over 
40 member countries and three associated countries. EUREKA supports R&D-based 
businesses and institutions through funding and partner-matching services. On a yearly 
basis, EUREKA supports more than 300 collaborative projects in a variety of industries, 
totaling over €1.2 billion. Projects can be launched in virtually all industry fields and 
technological areas — information and communications technology, manufacturing, 
water technologies, communications, biotechnology and energy. In July 2010, Israel 
took the reins of the EUREKA Network as its year-long chair. Leveraging Israeli best 
practices in technological innovation, the Israeli EUREKA chairmanship focused on 
promoting a culture of innovation and developing new sources of funding for start-up 
companies, small and medium sized enterprises and research institutions in Israel, 
throughout Europe and the world. Israel is among EUREKA’s most active participants; of 
EUREKA’s member and associated countries, Israeli companies have partnered in more 
than 10% of all EUREKA’s projects. 
Israel participates in the following active Era-Nets - The ERA-NET is instrument under 
R&D European programs .They designed to support public-public partnerships in their 
preparation, establishment of networking structures, design, implementation and 
coordination of joint activities as well as topping up of single joint calls and of actions of 
a transnational nature.Israel participated in ERA-NET’S under  :  
FP 7- : ARIMNet2, ERA-IB-2, ENTIII, EURONANOMED II, FLAG-ERA INCOMERA, Infect-
ERA, ICT- AGRO 2 ,MANUNET II,PathoGenoMics’etc… 
Horizon 2020:  JPco-fuND,M-era,M-eranet,ErasysBIO,TRANSCAN-2, 
WaterWorks2014,LEAR-ERA, ERA-NET Plus, NEURON-ERANET,ECO-Innovera,MED-
SPRING, etc… 
Israel is partner in several Joint Undertakings : Single European Sky Air Traffic 
Management Research (SESAR), Shift2Rail (S2R),Clean sky, Electronic Components and 
Systems for European Leadership (ECSEL) and others. 
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At a bilateral level, Israel implements a large number of R&D agreements with major 
European countries, including France, Germany, Italy, the Czech Republic, Finland, 
Greece, Hungary, Lithuania, Spain, Sweden, Turkey, Poland, Romania, the UK, Russia 
and others.  Israel Innovation Authority - ISERD also implements collaborative programs 
with European regions, clusters and industries, including Rusnano  - Russia, Cap Digital, 
Systematic and Medicin in France, ISS in Italy, CDTI and Accio in Spain and British 
Water in the UK. 
 
4.2 Optimal transnational co-operation and competition 
4.2.1 Joint programming, research agendas and calls 
This chairmanship additionally aided in developing new instruments to support 
innovation and industrial growth through R&D cooperation, in particular the EUREKA 
Cleantech Action and E!nnovest financial instruments. The other relevant collaboration is 
EUREKA, which incorporates 43 national funding schemes in virtually all European 
countries and the European Union. EUREKA facilitates approximately 400 projects every 
year, mobilizing  € 1.5 bn. of public and private funds. Over 40 % of EUREKA project 
participants are SMEs, which are the prime target group for Eurostars – a EUREKA-EU 
joint program aimed at supporting R&D-performing SMEs (including start-ups) through 
improved support mechanisms. Eurostars announces two open calls every year for close-
to-market projects led by SMEs in any industrial domain and funds approximately 150 
projects each year. 
Also among EUREKA’s activities are the Industrial Cluster sub-programs, which are 
initiated and managed by large multinational corporations (MNCs) in selected areas. The 
majority of clusters are active in information and communications technology (ICT), and 
energy and water technologies. Initiating companies in this project include Philips, 
Siemens, Veolia, Alcatel, Thomson, Ericsson, Nokia, France Telecom, Telefonica, 
Deutsche Telekom and other market leaders 
4.2.2 RI roadmaps and ESFRI 
The Ministry of Science and Technology started to work in 2010, on RI roadmap for 
Israel. The research was conducted by the  Samuel Neaman Institute- into the possible 
ways of working on an RI roadmap for Israel (Getz et al. 2010) and the potential 
benefits of following some of the examples of advanced countries. The purpose is to 
compile a database which would constitute the basis for a road map setting out the 
establishment of National Research Infrastructures in Israel.  The follow-up research 
began in May 2012 with the aim of completing a more comprehensive mapping of 
existing research infrastructures in Israel. The study offers an updated mapping of these 
infrastructures and describes the methodology used. A total of 119 research 
infrastructures appear in it, of which 87 were previously mentioned in the 2010 report, 
and the remaining 32 are newly mentioned.  The mapping shows that 58% of the 
infrastructures are located within academic institutes, 30% in public and governmental 
institutes and 12% within industry. To complete the picture of the research 
infrastructures available to researchers in Israel, the chapter includes information on ten 
international research facilities which are used by Israeli researchers and funded by 
government budgets. It also examines research infrastructures at the national level in 
relation to three main fields: nanotechnology and nanoscience, brain research, and 
genomics and proteomics. This allows for an assessment of the current availability of 
research infrastructures to researchers in these fields. 
VATAT decided to initiate a process of medium and long term strategical planning, to 
enable it to proactively,(and based on its set of priorities), develop and establish central 
academic research infrastructures, and to join existing international research 
infrastructures. Accordingly, in  2012 the assembly of the PBC decided to establish a 
permanent advisory committee (under the PBC) to deal with the issue of central 
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academic research infrastructures. The roles of the Committee were to create prioritized 
RI roadmap 
Following this research, VATAT created the “2013 Roadmap for Central Academic 
Research and Infrastructure in Israel”, in order to develop a more precise strategy for 
RI. In principle, new information concerning the Roadmap of Israel is expected to be 
published in the near future. 
Israel is already a member of an ESFRI projects such as GEANT, PRACE, INSTRUCT, 
EMBRC, ELIXIR, SHARE and  ESSurvey-1. The country is interested in maintaining its 
membership in the above RIs and in joining others such as other ERICs and ESO. 
4.3 International cooperation with third countries 
In this framework, two nations contribute a predetermined sum to a binational 
foundation intended to support cooperative projects. A board of directors is appointed by 
the two governments, and each fund establishes its own criteria and procedures. A 
designated non-profit organization manages the funds and administers grant payments. 
In addition to providing R&D projects with financial support, foundations search for 
business partners in both countries for the purpose of collaboration in technology 
development projects. Binational foundations do not receive equity or intellectual 
property rights in the companies supported, nor do they interfere in formulating or 
managing relationships between partnering companies 
US-Israel Binational Industrial R&D Foundation (BIRD) 
BIRD is a key catalyst for joint R&D between American and Israeli companies, focusing 
on emerging industries and novel technologies. Any pair of companies, one Israeli and 
one American, may jointly apply for BIRD support provided they have the combined 
capability and infrastructure to define, develop, manufacture, market, sell and support 
an innovative product based on industrial R&D. One of the two companies is typically 
involved in the development of cutting edge technologies while the other offers large-
scale product development and commercialization. The BIRD Foundation provides 
conditional grants for joint development projects on a risk-sharing basis. The Foundation 
funds up to 50% of each company’s R&D expenses associated with the joint project and 
repayments are due only if commercial revenues are generated as a direct result of the 
project. If a project fails, BIRD claims no repayments. Moreover, it requires no equity in 
the companies supported and no intellectual property rights, nor does it interfere in 
formulating or managing the relationship between the partnering companies.  
BIRD’s scope extends to communications, life sciences, electronics, software, cleantech 
and other technology sectors. Since its inception in 1977, BIRD has approved over 800 
projects, and cumulative sales of products developed through its projects amount to 
approximately  € 7.35 bn. 
Canada-Israel Industrial R&D Foundation (CIIRDF) 
The Canada-Israel Industrial R&D Foundation (CIIRDF) was established in 1994 to 
promote and support collaborative R&D between firms in Canada and Israel. CIIRDF 
offers grants for joint projects and searches for suitable partners in Canada and Israel to 
collaborate in technology development projects. Additionally, it is entrusted with the 
implementation of the Ontario agreement, focusing on projects connected with brain 
research and water technologies. CIIRDF’s support includes funding of both feasibility 
studies and full projects. Support can reach a maximum of 50% of the approved R&D 
costs of joint projects, up to a ceiling of € 603,200.  CIIRDF requires no equity in the 
companies it supports and no intellectual property rights in their products. It requires 
only that the nominal grant is repaid – interest free – on the basis of royalties if 
commercial revenues are generated as a direct result of the project. 
Korea-Israel Industrial R&D Foundation  
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The Korea-Israel Industrial R&D Foundation (KORIL-RDF) was established by the Korean 
and Israeli governments in 2001 in order to promote and support industrial R&D joint 
ventures between companies in Israel and South Korea. Funding can be obtained for up 
to 50% of the joint R&D costs of a project, to a maximum of € 754,000. At least 30% of 
the R&D development must be performed in either Korea or Israel. KORIL-RDF assists 
companies in both countries with partner searches in order to develop R&D 
collaborations. The foundation’s main office is in Seoul, Korea; an Israeli manager is 
based in Tel Aviv. 
Singapore-Israel Industrial R&D Foundation (SIIRD) 
The Singapore-Israel Industrial R&D Foundation (SIIRD) is a cooperative venture 
between the Singapore Economic Development Board (EDB) and the OCS in Israel to 
promote, facilitate and support joint industrial research and development projects 
between companies from Singapore and Israel. SIIRD assists in locating suitable R&D 
partners in both countries and shares in project risk. The Foundation may fund up to 
50% of approved costs of joint R&D projects. Total grants for the project may reach a 
ceiling of € 754,000 but may not exceed € 377,000 for any one year. SIIRD does not 
require equity or collateral and companies retain full intellectual property rights. SIIRD 
has to date approved approximately 112 joint projects with a total budget of over € 
120.64 m. 
US-Israel Science & Technology Commission and Foundation  
The US-Israel Science & Technology Commission (USISTC) provides a unique and highly 
beneficial environment for the promotion of binational cooperation at the highest levels 
of government and industry. Together with its implementation arm, the US-Israel 
Science and Technology Foundation (USISTF), the Commission focuses on developing 
areas of binational strategic importance, such as life sciences, space research and 
renewable energy. The Commission acts as a catalyst by identifying and removing 
impediments, as well as building a binational infrastructure for mutually beneficial 
economic and technological cooperation. 
BIRAX Regenerative Medicine Initiative 
BIRAX (the Britain-Israel Research and Academic Exchange Partnership) is a € 12.5 m. 
initiative of the British Council and the British Embassy in Israel in collaboration with the 
Pears Foundation and the UJIA. BIRAX funds cutting-edge research using stem cell and 
regenerative medicine therapies to tackle some of the world’s most challenging 
conditions and diseases including cardiovascular and liver disease, diabetes and 
Parkinson’s. Over € 8.75 m.  has been committed to 15 world-class projects including 
eight joint medical research projects announced in February 2015. These included 
research to use heart cells to restore damaged heart muscle and the use of breath tests 
for the diagnosis of Parkinson’s Disease. 
4.4 An open labour market for researchers 
4.4.1 Introduction 
Total national expenditure on education in 2013 amounted to  € 17.43 bn., 8.0% of the 
GDP. In 2013, the national expenditure on education (at constant prices) increased by 
6.8%, following an increase of 4.0% in the previous year, and 2.0% in 2011. In 2009 
(the last year for which data are available), there were some 54,400 researchers in 
Israel: 83% in the business sector and the remainder in the academic one. This 
breakdown matches the breakdown of R&D financing in Israel, with some 80% coming 
from the business sector. 
After increasing by 18.5% between 2005 and 2007 (the increase was entirely in the 
private sector), the number of researchers did not increase at all between 2007 and 
2009. This was apparently the result of the global recession, which also reduced the 
volume of business sector innovation financing. The fact that the number of researchers 
in the academic sector remained unchanged until 2009 – together with the relatively low 
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share of researchers in this sector – clearly indicates a supply problem regarding 
researchers at Israel’s universities.  
In 2014, Israel continued to lay emphasis on its main challenge in the area of flows of 
researchers, particularly in the academic sector: to attract researchers – both Israelis 
working abroad and foreign researchers – to do their research in Israel. The policy 
vehicle implemented to meet this challenge was the establishment of Excellence Centres 
(known by the generic name I-CORE – Israeli Centres of Research Excellence) as part of 
a new six-year plan which will offer significantly increased budgets for higher education, 
both for teaching and research: the plan, including the I-CORE initiative, was presented 
to the Government of Israel in March 2010 and its implementation continued during 
2012. The total six-year budget for the establishment of the 20 Centres is some € 320 
million out of a total budget for the plan of € 1,280 million.  
The main goals of I-CORE are to reinforce excellence in Israeli universities, improve their 
competitive position globally and reverse the brain drain by attracting back to Israel 
senior researchers who have worked abroad for an extended period. Together with the I-
CORE, the country has implemented the Israel National Brain Gain Programme with the 
intention of attracting back highly qualified workers (see section 6.1). 
4.4.2 Open, transparent and merit-based recruitment of researchers 
The profile of Israel mostly fits into an institutional type of staffing autonomy, where 
universities have freedom to decide on how to select their candidates. However, in 
general it is a transparent recruitment procedure.  The rules are known, and in most 
cases the members of the selection panel are publicly known and they normally consist 
of national and international experts in the pertinent field. 
The Ministry of Education has a special process for recognizing and validating foreign 
qualifications which is very important in Israel, given the huge number of immigrants 
entering the country every year. The high level of researchers’ qualifications make then 
suitable in any international market. In general, in Israel the outflow of researchers is 
greater than the inflow, and as mentioned in section (2.2.1) there is a need for highly 
qualified professionals both in industry and in academia. 
Given its high potential for new technologies and its vibrant academic environment, the 
country is very attractive to foreign researchers. Potential barriers are of course the 
language – although most research is carried out in English – and probably the instability 
related to the Middle East conflict in the area. 
4.4.3 Access to and portability of grants 
Grants in Israel are portable within the national territory but not abroad.  
4.4.4 Doctoral training 
Israel boasts 8 universities, 33 academic institutes, 23 academic colleges, and 4 
academic programs in colleges under the auspices of universities. Academic and teacher-
training colleges award Bachelor’s and Master’s Degrees (generally a non-research 
provision. Only universities may award all three degrees: Bachelor’s, Master’s and 
Doctorate. Universities are completely independent in the organization of the doctoral 
programs. 
The Council for Higher Education (CHE), established in accordance with the Council for 
Higher Education Law, 5718-1958, is the regulatory body responsible for the academic 
aspects of all institutions of higher education in Israel. The establishment of higher 
education institutions must be done with the authorization of the CHE. The majority of 
Israel’s academic institutions, including all the research universities, are financed by the 
state through the Planning and Budgeting Committee of the Council for Higher 
Education; however, sixteen of the Academic Colleges are not budgeted by this 
Committee, and Teacher Training Colleges are budgeted by the Ministry of Education. 
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According to the Council for Higher Education Law, 5718-1958, higher education 
institutions must receive recognition from the CHE in order to be considered an 
institution of higher education. The CHE also accredits institutions to award academic 
degrees. 
Quality Assurance in Israel is carried out by the Quality Assurance and Assessment 
Division of the Council for Higher Education, which evaluates study programs in 
universities and colleges. 
4.4.5 Gender equality and gender mainstreaming in research 
In general, the preparation of women, via higher education, for careers in Israel is 
similar to that in other developed countries, where more than half of the student 
population is female: in Israel, this is true also for PhD students. According to data from 
the 2009-2010 academic year, women constituted 54.7% of BA students at Israeli 
universities, 57.4% of MA students and 52.7% of PhD students. The share of women 
among degree recipients was also above 50% at all degree levels (BA – 57%, MA – 
55.4%, PhD – 50.7%). 
Since recipients of a PhD degree are more like to be the supply source of researchers, it 
is worth noting that in 2009, the labour force participation rate of holders of a PhD 
degree was a very high, 88.6% (compared to a national average of 56.9% in that year) 
with the rate among women only marginally lower than among men (86.8% compared 
to 89.7%), while the national participation rate in research for women, including PhDs, 
was much lower than for men in 2009 – 52.3% compared to 61.7%.  
In addition, the total unemployment rate among holders of a PhD degree in 2009 was a 
low 2.3% (compared to a national unemployment rate of 7.5% in 2009) with the rate 
among women holders slightly higher, at 3.6%. The share of female part-time 
employees with PhD degrees was higher than for males – 22.6% compared to 11.7% 
among males, but this female share is significantly lower than the share of part-time 
employees in total female employment in 2009, which was 39.6%. 
Nevertheless, even though the overall picture here seems to point to equal opportunities 
for men and women to become researchers in Israel, the data presented are indirect, 
and so no clear conclusions can be drawn about women’s research opportunities. There 
are certainly no policy regulations in place to correct any possibilities of discrimination 
against women in achieving research positions or to promote equal gender 
representation in academic and research committees, boards and governing bodies. Nor 
are there any regulations to guarantee the progression of female researchers with equal 
chances to their male counterparts, after career breaks. Paid maternity leave – for 3 
months – is given primarily to mothers. Should the mother decide to take longer leave, 
she is entitled to do so for up to a year without losing her job, but she is not paid for the 
extra 9 months of leave. Men can take part but not all of a woman’s statutory maternity 
leave. 
4.5 Optimal circulation and Open Access to scientific knowledge  
4.5.1 e-Infrastructures and researchers electronic identity 
The government decided at the end of 2013 to establish the national initiative “Digital 
Israel”. This project is working to formulate a national policy to promote digital economic 
growth, increase social welfare and reduce social inequalities through information and 
communication technologies. In addition, this venture is responsible for digital policy 
implementation while creating a coordinated and effective process, allowing the full 
potential of advanced technological infrastructure. 
The power of the “Digital Israel” initiative creates an increase in the demand for 
technology and innovative developments for public use, and thus contributes to the 
innovative ecosystem of Technology. Thanks to the expected change in public 
procurement policy and government regulation, it will be easier for the public sector to 
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incorporate innovative systems in the areas of IT or to offer advanced technological 
equipment. 
Furthermore, past experience has shown that the activities related to open access to 
government databases encourages the industry and business sector to develop 
innovative applications based on those databases. Therefore, the range of activities of 
the “Digital Israel” initiative would lead to an increase in supply from the private sector. 
In this way, the project will affect the entire economy – both as a supplier of technology 
products and services and an as  a customer needing  public services. 
 
 
4.5.2 Open Access to publications and data 
Open Access(OA) is a new initiative in Israel. There are two OA repositories in the 
country. The first, Israeli Scholar Works, was established in 2006 with the aim of 
collecting the scholarly output of Israeli studies, while the second is the Weizmann 
Institute of Science.  As of June 2015 there are 17 OA journals published in Israel which 
are indexed by DOAJ. Currently, no OA policies are registered with ROARMAP. The 
educational and research infrastructure in Israel is strong but Open Access initiatives 
have not been developed, and potential barriers for the development of OA are the lack 
of a national mandate and an OA strategy.  
MALMAD, the Inter-University Center for Digital Information Services, was set up in 
1998 by the Committee of University Heads. It aims to serve as a consortium for the 
acquisition, licensing and operation of information services to universities and colleges in 
Israel. MALMAD provides modern digital information services more efficiently and at a 
lower cost per user through inter-university cooperation and pooling of resources. 
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5. Framework conditions for R&I and Science-Business 
cooperation 
5.1 General policy environment for business 
Israel ranks 53rd in the World Bank’s “Ease of Doing Business Index 2016” (World Bank, 
2016), as to start a business in the country takes 56 days on average. The overall 
distance to the frontier is 70.56 (on a range of 1-100). The country has hardly been 
affected by the 2008 crisis, so no insolvency regulations have been needed. In general, 
only one out of ten entrepreneurs are successful with their ideas in the market, but 
society even encourages failure as a way to become successful. In comparison with 
previous years, however, the situation for doing business in Israel seems to have 
worsened. 
 
5.2 Young innovative companies and start-ups  
The environment in Israel is highly innovative for young companies and for start ups, so 
it is not without reason that the country is known as the “start-up nation”. (Senor & 
Singer, 2011).  
The OCS is very aware of the need for new ideas and hence it offers pre-seed and 
incubators programs (see section 2 and annex 4). A good structure of funds is also 
offered to SMEs, although there is no specific support for one market more than another.  
The aim of the OCS is also not to interfere with private VC, and support mostly firms 
which for any reason are unable to attract investment from private markets.  
The whole of the MAGNET program is structured to transfer knowledge and increase 
collaboration between universities and industry (for more details, see section 2.2).  At 
the public level there are a number of well-structured fora in big cities, such as Tel Aviv, 
Jerusalem and Haifa, where young entrepreneurs and experienced ones meet together 
on a regular basis, once or twice a month, to discuss ideas while drinking a beer that is 
normally sponsored by a private company. The country is very small and so the network 
of innovators is dense and well connected.   
5.3 Entrepreneurship skills and STEM policy 
Israel is among the leading countries in academic research, industrial and military 
research and development, and high-tech innovation. Yet Science, Technology, 
Engineering and Mathematics (STEM) education is compromised due to weak 
infrastructure, high student-to-teacher ratios, and small budgets (JCF, 2013). 
One challenge to Israel’s STEM potential is that many of Israel’s haredi (ultra-orthodox) 
have not participated in STEM education or its workforce to date. Fortunately, many 
companies and programs are emerging to integrate ultra-orthodox men and women into 
these sectors with great success, particularly given the keen and well-established 
analytical skills which the ultra-orthodox have developed through their Torah studies. A 
unique step in Israel’s STEM pipeline is compulsory military service for 18-year-olds. This 
minimum of 2 years of service for women and 3 for men provides skills and a work 
culture that instill innovation and entrepreneurial capabilities, but it also delays entry 
into the workfore. 
The OCS has launched some research and formed a committee directed by Eugene 
Kandel, the Chairman of the Israeli National Economic Council, and has concluded that 
there is a shortage in Israel of highly qualified workforce.  The steering committee 
recommended tackling the problem through a major operation on two fronts:  
- Reduce the gap between demand and supply of skilled workers in the employment 
market, by targeted actions  
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- Expand the scope of high school studying technology trends and encourage young 
people to choose academic studies in high-tech fields.  
Therefore a series of measures have been taken with different time spans:  
In the long term: it was recommended to find tools that encourage scientific excellence 
in education, and in particular the significant expansion of the Ministry of Education’s 
program of scientific-technological reserve. Other recommendations deal with the 
increasing supply of a relevant professional teaching force, further developing the use of 
digital platforms, and expanding programs for gifted students.  
In the medium term: the Commission recommended programs that increase access to 
higher education in engineering and science for people who do not currently meet the 
criteria for acceptance of these professions in academia. In addition, a program directed 
towards specific target populations: 
 The Arab sector: these days the program has begun integrating Arab society into 
high-tech industries formulated by the Office of the Commissioner for Employment. 
The program’s objective is to locate students and academics from the Arab 
population, starting with high-tech industry, and offer them personal guidance, 
training and placement assistance, thereby creating a network of contacts at the 
beginning of their careers.  
 Haredi (ultra-orthodox) population: the committee introduced a pilot program called 
“Talpiot Haredim”, aimed at training high-quality small groups of outstanding young 
people anxious to integrate in the society. This group would constitute an elite group 
that would lead the integration of the ultra-orthodox community in the Israeli high-
tech industry and help to generate a broader process of integration into the high-
technology sector. This program is currently under development. 
In the short term: the Commission recommends, among other things, the formulation of 
a plan to refresh the knowledge of experienced engineers who are not currently working 
and who have the potential to develop programs to update Israeli academicians living 
abroad. 
To address these challenges requires a long and steady activity, and therefore, in 
addition to the recommendations above, the Committee intends to establish a steering 
committee headed by the Commissioner of Labor and Chief Scientist, and attended by 
representatives of ministries and relevant agencies. The purpose of the team will follow 
the progress of implementing the recommendations and implementing them, coordinate 
activities and initiate additional programs, among others on the integration of women in 
high-tech. All this is an alongside ongoing consultation with the relevant employers. 
5.4 Access to finance 
In 2014 a peak was reached for Israeli high-tech companies, as they managed to raise € 
2.56 bn. and made a hundred exits worth about seven billion dollars, including mergers 
and acquisitions to approximately € 3.61 bn., and IPOs about € 1.58 bn.  Israeli venture 
capital funds raised € 688 m. this year, an increase of 68% compared with 2013, and 
the highest recruitment in the past six years. Investments of Israeli venture capital 
funds into local high-tech companies stood at € 432 m. in 2014. 
Reduction of base turnover - an approved enterprise (prior to Amendment No. 60) and a 
beneficiary enterprise are entitled to reduce their base turnover by 10% in each tax year 
starting from the record year, provided they meet certain cumulative conditions 
regarding the rate of R&D expenses, the percentage of employees with academic 
qualifications in engineering, computers, life sciences or exact sciences, and products 
replacement or investments in productive assets. The benefit is contingent on 
demonstrating the enterprise’s compliance with the base turnover reduction criteria 
pursuant to Regulation 1 of the Regulations for Encouragement of Capital Investments 
(Reduction of Base Turnover). Among others, Regulation 1 states that the total R&D 
expenses incurred by an enterprise in a tax year in respect of which the OCS approval 
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was obtained, or in the preceding year, will not be lower than 7% of the turnover in the 
tax year and the preceding year. 
Section 20a to the Income Tax Ordinance allows the deduction for tax purposes of a 
company’s R&D expenses incurred for the purpose of promoting and developing the 
company. According to this section, under the conditions prescribed therein, expenses 
incurred in scientific research in industry, agriculture, transportation or energy approved 
by the OCS will be deductible on a current basis in the tax year in which they are paid. 
As for expenses incurred in scientific research which are not approved by the OCS, these 
will be deductible in three annual installments starting from the tax year in which they 
are paid. 
From a deeper reflection on the financing needs of technological companies in Israel it is 
evident that the current business environment allows sufficient financing support to 
companies at early stages. This is leading to the establishment of many new start-ups. 
As a result, there is some “inflation” of seeds and a major recruitment stage at Round A, 
which is characterized by a marked increase in the financing needs of companies and the 
supply of capital being concentrated in the hands of venture capital funds. On the other 
side of the fence, there is a trend in recent years beyond the strategy of “big bets”:  in 
other words, investing large amounts of money in few companies rather than 
diversifying the investment in a smaller number of companies. In this way, the supply of 
capital is small compared to the number of companies seeking to recruit funding 
especially given the excess demand for financing previously described. A shortage of 
funds makes it difficult to integrate many companies and to raise funds for all of them to 
continue operations, forcing them to shrink and sometimes to close (“Series A crunch”).  
This phenomenon was the catalyst for the establishment of funds focusing on early stage 
investments (micro VC) that is starting to happen today in Israel. This means there is a 
stage funding gap which in Israel is estimated to be around € 100-200 m.  
5.5 R&D related FDI 
Israel’s success in technology and innovation is attracting investors from around the 
world and especially in the field of venture capital. In recent years, the presence of 
foreign funds in Israel has been growing stronger and subsequently is increasing the 
dependence of Israeli high-tech companies on foreign capital. To put this fact in 
perspective, during 2013 foreign investors financed 75% of all investments in Israeli 
companies and about 85 % of total capital raised by Israeli venture capital funds. In 
fact, foreign funding accounts for about half of the total funding for R&D in Israel (see 
Table 2). Most of the foreign capital invested in Israeli venture capital originated in the 
United States, but the last three years have shown a growing interest from investors 
from Asia, especially from China. 
The inflow of foreign investment contributes significantly to the growth and R&D 
activities of the high-tech economy. However, reliance on foreign sources reveals local 
industry fluctuations and crises in the global market, and at a time of crisis, foreign 
investors might reduce their investments in markets far away, as was the case during 
the financial crisis in 2008 when investments in Israeli high-tech dropped by 50%. In 
view of this, it is vital to create local financing alternatives, especially so as to make the 
stock market an attractive alternative and an efficient way to raise capital through 
technology companies.  
5.6 Knowledge markets 
Israel has a well-developed intellectual property system, which underpins the country’s 
status as one of the most innovative economies. A significant development in Israeli 
intellectual property law is the introduction of the Copyright Act 2007, which, inter alia, 
replaced the doctrine of fair dealing by that of fair use, thus providing a more flexible 
approach to copyright exceptions – an exceptional step which few jurisdictions have 
taken so explicitly. Israel has also reached an agreement with the United States to 
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amend certain pharmaceutical IPR provisions relating to patent-term extension, patent-
application publication, and data exclusivity (WTO, 2012) 
5.7 Public-private cooperation and knowledge transfer 
Israel has a 3.3 % share in public-private publications, more than double the European 
average of 1.8%. In 2012, private funding for public R&D was 1.42 % of the GDP in 
Israel, slightly above the EU average of 1.1 %. 
The main public knowledge transfer is done through MAGNET (the acronym in Hebrew 
for Generic Pre-Competitive R&D) programs. These programs encourage collaboration 
among industrial companies and between companies and researchers from academic 
institutions through several instruments. These instruments seek to develop Israel’s 
industrial infrastructure by supporting R&D activities and sharing technological 
knowledge among its participants. Some of the main istruments are
8
: 
 Magnet Consortia: This program supports the formation of consortia made up of 
industrial companies and academic institutions in order to jointly develop generic, 
pre- competitive technologies.  
 Magneton: The program promotes technology transfer from academia to industry 
via mutual cooperation between an individual company and an academic research 
group, reducing the firm’s uncertainty regarding the use of novel technology.  
 Users Association: An “Advanced Technologies Users Association” is a group of 
industrial companies involved in the dissemination and assimilation of generic 
advanced technology and in the sharing or utilizing of a common technology. This 
instrument also enables the creation of a demonstration site for the service of the 
association’s members in their development activity. 
 Nofar – Industrial Application of Academic Research: The program is designed 
to bridge the gap between know-how within academia and the needs of the industry. 
It does so by encouraging the support of applied academic research activity by an 
industrial company(already commented on in Section 2.2). 
 Kamin - The program is designed to translate academic research achievements into 
technologies of interest to the Industry. It serves as an additional bridge between 
pre-commercial research and industrial research.  
 Telem Forum is a voluntary partnership between The Office of the Chief Scientist in 
The Ministry of Economy, The Office of The Chief Scientist in The Ministry of Science 
& Technology, The Planning and Budgeting Committee of the Council for Higher 
Education the Ministry of Defense and the Ministry of Finance. TELEM encompasses 
several programs aimed at establishing a national infrastructure for R&D in areas 
that are of common interest to the forum’s members.  
 Tzatam  This TELEM instrument is designed to assist experienced companies who 
provide research services in the field of Life Sciences by supporting the purchase of 
expensive equipment, thus strengthening Israel’s Life Sciences R&D capabilities. 
These purchases provide entities in both industry and academia the ability to 
broaden the scope of the research they conduct. OCS equipment purchase grants 
assist in the validation of scientific and technological feasibility and in the receipt of 
approvals to perform clinical trials.  
 Basic and Applied Nanotechnology Research: From 2005 to 2012, six 
nanotechnology academic research centers have been founded and put into operation 
in Israel: first at the Technion, then Tel Aviv University, Hebrew University, Bar-Ilan 
University, Ben-Gurion University, and The Weizmann Institute. The program has 
established strong capabilities in design and fabrication of nanodevices which has 
aided research in academia and development in industry. A follow-up program has 
been devised for 2012-2016, the main goal of which is to establish a strong 
                                           
8
 In section 2.2, the recents developments (those implemented in the last three yeears) concerning these programs have 
been discussed. Here there is a more general overview, including older programs. 
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Nanotechnology industry by transferring technologies from academia to industry and 
by creating a pool of skilled Ph.D. and an M.Sc. graduates in Nano-science. 
 National Bio-Bank: A bio-bank is an organized collection of human biological 
material and associated information stored for one or more research purposes. Bio- 
banks allow researchers to analyze data representing larger numbers of individuals 
than to which they would typically have access, thus profoundly improving the 
efficient use of biological information and hastening new medical discoveries. The 
State of Israel, having realized the importance of such a repository to the 
advancement of medical innovation, has founded a national bio-bank. Through The 
Office of the Chief Scientist of the Ministry of Economy and Trade, The Office of The 
Chief Scientist of the Ministry of Science & Technology, The Planning and Budgeting 
Committee of the Council for Higher Education and The Ministry of Finance 
 Support for Israeli Research Institutions: This program assists research 
institutions with clear links to industry in strengthening their technology 
infrastructure and developing relevant technologies and products.  
 Long-Term R&D Support for Large Companies with Substantial R&D 
Investment: This program is designed to encourage long-term R&D. (see section 
2.2 for more details)  
 National Institute for Biotechnology in the Negev (NIBN) :The NIBN was 
established within Ben-Gurion University in 2005 with the co-investment of several 
government entities, including the OCS, to create a more effective multidisciplinary 
bridge between basic and applied research in biotechnology and for the emergence of 
a successful biotechnology industry in Israel and the Negev. The focus of the 
institute’s research includes structural biotechnology, computational biotechnology, 
human genetics, functional genomics, nanomedicine and immune system 
biotechnology.  
Israel has a well designed program for technological Incubators. The primary goal of this 
program is to transform innovative technological ideas in their early, high-risk stages 
into viable startup companies capable of raising money and operating on their own. 
Additional goals of the program are: promote R&D activity in peripheral and minority 
areas, create investment opportunities for the private sector, including venture  
capitalists,  transfer technologies from research institutes and implement them into  the 
industry and enhance the entrepreneurial culture in Israel. The program is subject to the 
R&D law with regards to manufacturing, royalties and IP rights. 
Another interesting initiative is Academitech. It is a competition at the student level 
established by the OCS, for the development of an innovative product. The competitors 
are groups of students from institutions recognized by the Council for Higher Education 
that will present a Proof of Concept for a commercial product. Any field of study is 
eligible to enter the competition. Academitech is a competition at the student level 
established by the OCS, for the development of an innovative product. The competitors 
are groups of students from institutions recognized by the Council for Higher Education 
that will present a Proof of Concept for a commercial product. Any field of study is 
eligible to enter the competition. 
Israel, as the ‘Startup Nation’, is well known for its entrepreneurial spirit, which is also 
well reflected in the different types of accelerator programs, although private funded, 
that have been launched in the past three years. The most important part of an 
accelerator, besides the mentors and the funding (through VC) as an entrepreneur from 
any program, is the fact that many of them offer a shared space. As most of the startups 
are going through the same difficulties, this is the best way to make sure that they really 
work harder on the achieving their goals. It is also the best place for mutual 
brainstorming sessions, problem sharing , self-discipline, focus and the most important – 
solution sharing. The impact of the accelerator on startups has been huge. 
National Institute for Biotechnology in the Negev (NIBN) :The NIBN was established 
within Ben-Gurion University in 2005 with the co-investment of several government 
entities, including the OCS, to create a more effective multidisciplinary bridge between 
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basic and applied research in biotechnology and for the emergence of a successful 
biotechnology industry in Israel and the Negev. The focus of the institute’s research 
includes structural biotechnology, computational biotechnology, human genetics, 
functional genomics, nanomedicine and immune system biotechnology.  
 
5.8 Regulation and innovation 
In Israel, no specific research has been carried out covering the impact of regulation and 
innovation. Although the country has high levels of bureaucracy, it seems to find ways to 
be among the leaders in innovation. 
5.9 Assessment of the framework conditions for business R&I 
The framework conditions are in place to lead to successful investment in Israel.  The 
country has a highly qualified population, with a high proportion of entrepreneurs, and a 
vibrant academic environment that cooperates with industry, and all of this creates a 
successful environment for business. The only weakness of the system is that it is highly 
dependent on foreign investment. 
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6. Conclusions 
6.1 Structural challenges of the national R&I system 
The Israeli research and innovation system faces three serious structural challenges, 
stemming both from internal factors and from shifts in the global marketplace. These are 
long-term challenges that pre-date the global economic crisis that started in 2008, even 
though the crisis may have highlighted their urgency, and they require the kind of long-
term responses that helped the Israeli research and innovation systems excel in the 
previous two decades. 
Like most structural challenges, these ones are extensively interrelated and touch on 
many other issues of concern to policymakers, but they are distinct enough to outline 
separately as follows: 
1. Making up for the “lost decade” 
Investments in Israeli higher education and research essentially stagnated during the 
first decade of this century. From 2000 to 2010, budgets effectively declined compared 
to the growth in population. By the middle of that decade, investment per student had 
declined by 9% compared to 1995 and the average age of faculty in exact science 
departments was over 55. Investment in research infrastructures also fell behind, forcing 
universities to rely mainly on donations.  
In output terms, the first results could be seen by the end of the decade in the decline in 
the country’s share of world scientific publications, which declined from 1.1% in 2000 to 
0.9% in 2009, proportionately a radical decrease for a small country highly dependent 
on research and innovation. As far as citation impact is concerned, the decline was less 
acute, from 12th to 13th place worldwide, according to a study of Israeli scientists’ 
publications (Samuel Neaman Institute, 2011). The lower drop in citation index rankings 
was attributed to the impact of papers of older researchers many of whom have reached 
retirement age. 
As a result of this stagnation, the brain drain became an acute problem. However, by the 
end of 2015, the number of academics living abroad had slowed to a halt.  It had 
remained steady between 2012 and 2014, after an increase of 19% between 2010 and 
2012 during the height of the social protests in Israel, according to a survey conducted 
by the Israel National Brain Gain Program and released by the Ministry of Economy and 
Trade. 
2. Heavy Reliance on ICT 
The Israeli economy is heavily reliant on ICT based exports and clusters of industries 
based on a deep pool of talent that stretches from academe to small ICT based start-
ups. The Israeli economy offers a fascinating illustration of extraordinary success in 
innovation, particularly in Information and Communications Technologies (ICT), which 
came largely as a result of a concerted, long term strategy of government support for 
commercial R&D, which levered the potential of a highly skilled labor force. Yet, the 
benefits from the rapid growth of the High Tech sector eluded the rest of the economy, 
thus giving rise to a “dual economy”: a high rate of growth for ICT and a mediocre 
growth rate for the economy as a whole. (Trajtenberg 2006) 
The success of ITC industry is what enabled Israeli R&D based industries to attract 
substantial investment from business in ICT-based industries, and this in turn was one of 
the reasons for the reduction in total government support of business-based R&D by 
36.3%9 compared to inflation adjusted prices in the year 2000.  
Policymakers have been aware of this situation for years, and have been encouraging 
Israeli industry to diversify through a variety of measures and initiatives. Yet they face a 
                                           
9
 Statement by Avi Hasson, Chief Scientist in the Ministry of Economy and Trade, October 2011 
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challenging dilemma: an in-depth study10 has proven that government support of mainly 
ICT-based industries is critical for economic growth in a highly competitive world, even 
though the majority of funding for innovation comes from the business sector. This 
means that a decision to divert a major part of the government resources intended to 
support industrial R&D to other new fields would cause extensive economic damage. 
Technology-based exports, predominantly based on ICT, account for close to half of 
Israeli exports. There are no data on exactly what percentage of these exports are based 
on government support programs, but by definition, government support is extended to 
the riskiest R&D ventures, those that give Israeli ICT exporters their competitive edge. 
Hence, diversion of resources from ICT would deprive Israeli industry of an important 
element of its competitive capacity. 
Yet not diversifying is also not seen as a good long range option (Trajtenberg, 2006). 
The overall returns on the heavily ICT-based Israeli venture capital industry have been 
disappointing during the past decade. Since a major part of the Israeli innovation system 
is predicated on creating new ICT companies, this is a strong indicator that the 
innovation system needs new engines of growth.  
In the past decade, the government largely abandoned the field of thematic university-
based research in all civilian fields except for agriculture, and most of the thematic 
research conducted in Israeli universities is through the country’s participation in the EU 
Framework Programs. Extensive thematic research is carried out in Israel’s large and 
classified defense R&D system, and there is anecdotal evidence 11 of major spill-over 
effects onto the civilian-based ICT innovation system. This successful example shows 
that developing new areas of expertise requires not only extensive human and physical 
infrastructures, but also a judicious mix between thematic academic research and 
project-oriented R&D.  Hence, the challenge to develop non-ICT based innovative 
industries must be cast not only in terms of industrial policy, which is managed by the 
OCS in the Ministry of Economy and Trade (OCS), but also in terms of research policy 
managed by VATAT and by the Israeli Science Foundation. 
3. VC Environment
Venture Capital is an essential part of the Israeli innovation system. To put things in 
proportion, the total annual investment by VC in Israeli technology start-ups during the 
past decade has usually been at least four times higher than the total government 
budget to support innovation in all firms from start-ups to major corporations. 
In 2014, 12 Israeli venture capital funds raised € 688 m., the highest quantity raised by 
such funds in six years. The year’s fund increased by 68 % from the € 409 m raised by 
11 VC funds in 2013, and was 18% above the 10-year average of € 585 m. 
Four veteran Israeli VC funds managed to raise more than € 75 m. each and accounted 
for 64% of total capital raised in 2014. Carmel Ventures’ fourth fund attracted the 
largest amount – € 146 m., and the average fund size in 2014 reached € 57 m. The 
increase reflects the raising of more medium-sized funds and fewer micro VC funds than 
in each of the previous two years.  During the 2011-2014 period, micro venture capital 
funds – managing capital below € 37 m. – accounted for 14% or € 330 m. of the total 
amount raised by venture capital funds. However, the micro VC trend seems to have 
abated, as only three new funds were established in 2014, compared to an average of 
nine over the previous three years.  
10
 Lach, Wasserteil., & Prizant, 2008 
11
 Eilam, 2011 
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Table 4: Policy measures and assessments 
Challenges Policy measures/actions Assessment in terms of appropriateness, efficiency 
and effectiveness 
Redressing 
the “lost 
decade” in 
academic 
research 
1. Six-year VATAT plan,
increasing research
budgets and retaining 
more researchers 
2. I-CORE programs for
centres of research
excellence 
The program to repair and renew academic research 
appears to be both appropriate and comprehensive, 
and it seems at least to have halted the decrease in 
the number of academicians in Israel. 
Over reliance 
on ICT-based 
innovation 
1. OCS programs
encouraging R&D in new 
fields including 
traditional industry. 
2. Government
participation in dedicated 
biotech VC fund. 
OCS programs are generally effective in addressing 
their immediate target. However, the OCS cannot 
devote more of its limited budget devoted to non-ICT 
commercial R&D because the funds are needed by 
proven generators of jobs and wealth in ICT. The 
drive to diversify must go far beyond the immediate 
target of reducing the risk of commercial R&D. If the 
I-CORE programme does indeed produce both the 
knowledge and human skills needed to develop new 
fields, this is only part of the infrastructure needed 
for diversification. 
Precarious 
state of 
Venture 
Capital 
Government measure to 
insure 25% of the risk of 
Israeli institutional 
investors who join funds 
as limited partners 
It is still early and difficult to assess but there is a 
positive reaction from the Israeli VC industry in terms 
of the volume of funds raised.  
6.2 Meeting structural challenges 
Two of the three challenges outlined above – the quality of university research and the 
precarious status of Israeli venture capital – have been addressed by actions intended to 
directly mitigate the problems in the country’s research and innovation systems. The 
third challenge – the need to diversify the ICT-centric technology sector – has been 
addressed by a variety of measures, but this is a long-term and complex challenge that 
defies simple solutions. 
It is early to assess the effectiveness of the six-year VATAT plan (2011-2017) and the I-
CORE programme. In 2015 the first indicators of success were that the brain drain 
seems to have stopped.  New researchers are being retained by universities and the 
number of researchers returning to Israel to join I-CORE programs has increased.
12
 
However, the real tests of the programme will be in general academic quality, as 
measured both by bibliometric and other indicators, and by the commercial technologies 
that result from this basic research. Both of these will take a long time to materialize. 
There has been some criticism in academic circles of the I-CORE åprograms, with 
academics saying that the preferred status of I-CORE centres will be at the expense of 
other academic researchers. Yet so far there is little evidence to support this claim. In 
general, the response to the challenge of the “lost decade” seems comprehensive and 
integrative, especially since it does not seek to turn the wheel back but to create a 
research environment suited to the conditions of the 21st century. 
As reported above, the large venture capital sums attracted by Israeli high-tech firms 
(€2.40 bn. in the first 9 months of 2015) can be interpreted as a positive reaction by the 
Israeli VC industry towards the government policy. However, the effectiveness of the 
response depends on so many extraneous factors that it is hard to judge on its own 
merits. Israeli institutional investors, like their colleagues in other countries, are judged 
12
 At the end of 2015 there was still no information on the effectiveness of those plans. 
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by harsh criteria, such as performance per quarter. The decision about whether to lock 
up capital for seven to ten years because of the government’s commitment to underwrite 
part of the risk depends to a large extent as much on current market conditions as on 
strategic considerations about the composition of each investor’s portfolio. If Israeli 
investors are choosing to enter the programme, this is only one part of each fund 
management company’s struggle. They then have to persuade investors abroad, who 
should make up the majority of each limited partnership, to invest in their fund, despite 
the current tumultuous state of capital markets.  
The challenge of diversification beyond ICT is both more complex and more intriguing. 
Proof that it is achievable can be seen in the development during the past decade of a 
substantial cluster of Israeli companies in the field of medical devices, which is based on 
the skills and entrepreneurial drive of researchers and technologists from a broad range 
of fields ranging from medicine to ICT. However, even if the various measures 
promulgated and enacted by the OCS from biotechnology through nanotechnology to 
cleantech are successful, and if the I-CORE programme does indeed lead to the 
development of skills needed for the next generation of technologies, this might not be 
enough. The various clusters of Israeli companies in ICT are predicated on two additional 
conditions. The first is markets in a state of rapid growth in which relatively small Israeli 
companies can make their mark. The second is the existence of a financial ecosystem 
that can develop these companies. Even if these issues have not been resolved now, it is 
clear that various government initiatives, if seen in concert, are trying to address the 
complexities of this problem. 
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Annexe 1 - List of the main research performers 
TOP 10 based on publications 
1. Hebrew University of Jerusalem
2. Tel Aviv University
3. University of Haifa
4. Ben-Gurion University of the Negev
5. Technion - Israel Institute of Technology
6. Weizmann Institute of Science
7. Bar-Ilan University
8. The Interdisciplinary Center
9. Bezalel Academy of Arts and Design
10. The College of Management – Academic
 Studies 
TOP 10 firms based on R&D doers 
1. TEVA PHARMACEUTICAL INDUSTRIES
2. ELBIT SYSTEMS
3. IAI
4. MELLANOX TECHNOLOGIES
5. NICE-SYSTEMS
6. CHECK POINT SOFTWARE TECHNOLOGIES
7. ORBOTECH
8. STRATASYS
9. CERAGON NETWORKS
10. RADWARE
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Annexe 2 - List of the main funding programmes 
Name of the funding 
programme 
Timeline Budget Target group 
Large Companies’ R&D 
Centers in Israel's 
Periphery 
2-3 years 
€ 321 m. (annual) 
Big Companies. 
Support for Traditional 
Industry 
permanent Mature SMEs. 
Encouragement of 
R&D in Space 
Technologies 
permanent Seed companies. 
Mature SMEs. Big 
Companies.   
Industrial R&D in 
Agriculture 
permanent Seed companies. 
Mature SMEs. Big 
Companies.   
MEIMAD - Encouraging 
R&D of Dual Use 
Technologies 
30 months Seed companies. 
Mature SMEs. 
Research Institutes 
and Academia.  
Development of 
Technological 
Solutions for People 
with Special Needs 
permanent Pre-seed companies. 
Seed companies. 
Mature SMEs.  
Israeli National 
Renewable Energy 
Center – Testing and 
Validation Track 
permanent Seed companies. 
Mature SMEs. Big 
Companies.   
R&D preparatory 
Program for 
Traditional Industry 
permanent n.a. Mature SMEs. 
KIDMA Advancement 
of Israeli Cyberspace 
permanent n.a. Pre-seed companies. 
Seed companies. 
Mature SMEs. Big 
Companies.   
Assistance of Seed 
Companies 
permanent n.a. Pre-seed companies. 
Seed companies.  
Tnufa permanent n.a. Entrepreneurs. Pre-
seed companies.  
Technological 
Incubators  
permanent n.a. Entrepreneurs. Pre-
seed companies.  
Biotech Designated 
Incubators 
permanent n.a. Entrepreneurs. Pre-
seed companies.  
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Technological Based 
Industrial Incubators 
permanent n.a. Seed companies. 
Israeli National 
Renewable Energy 
Center Venture Track 
permanent € 12 m Entrepreneurs. Pre-
seed companies. Seed 
companies.  
Life Sciences VC Fund 10 years € 165 m Pre-seed companies. 
Seed companies. 
Mature SMEs.  
Investment in VC-
Backed Companies in 
the field of Alternative 
Fuels for 
Transportation 
9 years € 75 m Pre-seed companies. 
Seed companies. 
Mature SMEs. Foreign 
Companies. Direct 
Investors.  
Reduction of 
Greenhouse Gas 
Emission 
permanent n.a. Seed companies. 
Mature SMEs. Big 
Companies.  End 
Users.  
Institutional 
Investment in Israeli 
High Tech 
permanent n.a. Direct Investors. 
MAGNET Consortia permanent n.a. Pre-seed companies. 
Seed companies. 
Mature SMEs. Big 
Companies.  Research 
Services Companies. 
NGOs. Foreign 
Companies. Research 
Institutes and 
Academia. End Users. 
MAGNETON - 
Encouragement of 
Technology Transfer 
from Academia to 
Industry 
permanent n.a. Mature SMEs. Big 
Companies.  Research 
Institutes and 
Academia.  
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NOFAR - Industrial 
Application of 
Academic Research in 
The Fields of Nanotech 
and Biotech, Medical 
Devices, Water and 
Energy 
1.5 years € 105.000 Seed companies. 
Mature SMEs. Big 
Companies.  Foreign 
Companies. Direct 
Investors. Research 
Institutes and 
Academia.  
KAMIN - Promotion of 
Selected Applied 
Academic Research 
permanent n.a. Research Institutes 
and Academia.  
Users Association permanent n.a. Seed companies. 
Mature SMEs. Big 
Companies.  End 
Users.  
TZATAM Equipment 
Purchase Grants for 
Life Sciences Research 
3 years € 7 m Research Services 
Companies. Research 
Institutes and 
Academia.  
Basic and Applied 
Nanotech Research 
Support 
7 years €165 m Research Institutes 
and Academia.  
National Biobank 5 years € 7.5 m Pre-seed companies. 
Seed companies. 
Mature SMEs. Big 
Companies.  Research 
Services Companies. 
NGOs. Foreign 
Companies. Research 
Institutes and 
Academia.  
Isragrid Permanent n.a. Pre-seed companies. 
Seed companies. 
Mature SMEs. Big 
Companies.   
Support for Long-Term 
R&D of Large 
Companies with 
Substantial R&D 
Investment 
Permanent n.a. Big Companies. 
Support for Israeli Life 
Sciences and 
Traditional Industry 
Research Institutes  
Permanent n.a. Research Institutes 
and Academia.  
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Israeli National 
Renewable Energy 
Center - Research 
Track 
Permanent n.a. Research Institutes 
and Academia.  
NIBN National 
Institute for 
Biotechnology in the 
Negev 
Permanent n.a. Research Institutes 
and Academia.  
Bi-National 
Agreements 
Permanent n.a. Pre-seed companies. 
Seed companies. 
Mature SMEs. Big 
Companies.   
Bi-National Funds 
USA, Canada, China, 
Korea 
Permanent n.a. Pre-seed companies. 
Seed companies. 
Mature SMEs. Big 
Companies.   
The Global Enterprise 
R&D Cooperation 
Framework 
Permanent n.a. Seed companies. 
Mature SMEs. Big 
Companies.  Foreign 
Companies.  
Program to Encourage 
the Establishment of 
R&D Centers in Israel 
for The Service of The 
International Financial 
Community 
Permanent n.a. Foreign Companies. 
Project Centers for 
Multinational 
Companies 
permanent n.a. Seed companies. 
Mature SMEs. Big 
Companies.  Research 
Services Companies. 
Foreign Companies. 
Research Institutes 
and Academia.  
EU Framework 
Program 
permanent n.a. Entrepreneurs. Pre-
seed companies. Seed 
companies. Mature 
SMEs. Big Companies. 
Research Services 
Companies. NGOs. 
Research Institutes 
and Academia. End 
Users.  
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EUREKA-Eurostars permanent  n.a Seed companies. 
Mature SMEs. Big 
Companies.   
EEN  Enterprise 
Europe Network 
permanent n.a Entrepreneurs. Pre-
seed companies. Seed 
companies. Mature 
SMEs. Big Companies. 
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Annexe 3 - Evaluations, consultations, foresight exercises 
In Israel two main foresight exercises were conducted in 2014-2015: 
The first exercise was by the OCS, as analyzed in the text in section 2.2.1 . It can be 
accessed online (OCS, 2015) though unfortunaly only in Hebrew. 
The second was by the central bank of Israel. However, it is much more general, as it 
applies to the whole economy, employment, debt, and monetary policy and therefore it 
was far from the thematic of the current paper, and so was not introduced into the 
discussion.  It can be accessed online in English (Bank of Israel, 2013b). 
How to obtain EU publications 
Our publications are available from EU Bookshop (http://bookshop.europa.eu), 
where you can place an order with the sales agent of your choice. 
The Publications Office has a worldwide network of sales agents. 
You can obtain their contact details by sending a fax to (352) 29 29-42758. 
Europe Direct is a service to help you find answers to your questions about the European Union 
Free phone number (*): 00 800 6 7 8 9 10 11 
(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed. 
A great deal of additional information on the European Union is available on the Internet. 
It can be accessed through the Europa server http://europa.eu 
doi:10.2791/198204 
ISBN 978-92-79-57800-7 
JRC Mission 
As the Commission’s  
in-house science service,  
the Joint Research Centre’s 
mission is to provide EU  
policies with independent,  
evidence-based scientific  
and technical support  
throughout the whole  
policy cycle. 
Working in close  
cooperation with policy  
Directorates-General,  
the JRC addresses key  
societal challenges while  
stimulating innovation  
through developing  
new methods, tools  
and standards, and sharing 
its know-how with  
the Member States,  
the scientific community  
and international partners. 
Serving society  
Stimulating innovation 
Supporting legislation 
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